A Study on Azhal Keel Vaayu (அழல் கீல் வாயு)  (Osteoarthritis) by Aruljothi, V
A STUDY ON 
AZHAL KEEL VAAYU 
(Osteoarthritis) 
 
Dissertation Submitted To 
THE TAMIL NADU Dr. M.G.R. Medical University 
Chennai – 32 
 
For the Partial fulfillment for the Award of Degree of 
DOCTOR OF MEDICINE (SIDDHA) 
(Branch – III, SIRAPPU MARUTHUVAM) 
 
 
 
 
 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
Government Siddha Medical College 
Palayamkottai – 627 002. 
APRIL – 2013 
ACKNOWLEDGEMENT 
First, I am extremely grateful to the divine power enlightened my path with 
blessings and strengthened me in all aspects towards the milestone successfully. 
I express my deep sense of gratitude to our Principal                 
Dr.N.Chandra Mohan Doss. M.D(S)., and Dr.S.Soundararajan. M.D(S)., Vice 
Principal, Government Siddha Medical College, Palayamkottai for granding 
permission to execute this dissertation work in the college premises. 
 It is a honour for me to express my sincere thanks and gratitude to Asso. 
Prof. Dr.S.Kaniraja. M.D(s)., Head of the department, Post Graduate Sirappu 
Maruthuvam  for his support and guidance to do this study. 
It is my pleasure to express grateful thanks to Dr.D.Rajasekar. M.D(S)., 
lecturer and Dr.A.S. Poongodi Kanthimathi. M.D(S)., Lecturer Post Graduate 
Sirappu Maruthuvam for rendering their valuable suggestion and guidance. 
I convey my sincere thanks to Dr.S.Ramaguru. B.Sc., M.B.B.S., 
M.S(ortho)., D.Ortho., Professor, Department of Orthopaedics, Department of 
Sirappu Maruthuvam, Govt Siddha Medical College, Palayamkottai. 
My sincere thanks to Prof. N. Nagaprema. M.Sc., Head of the department, 
Department of Bio-chemistry and Mr. M. Kalaivanan. M.Sc., Lecturer, 
Department of Pharmacology, Government Siddha Medical College, 
Palayamkottai. 
It is my duty to express my cheerful thanks to all those who encouraged and 
supported during the whole study period. 
 
CONTENTS 
           PG.NO 
INTRODUCTION        1 
AIM AND OBJECTIVES        3 
REVIEW OF LITERATURES       
I. REVIEW OF SIDDHA LITERATURES   5 
II. REVIEW OF MODERN LITERATURES  33 
MATERIALS AND METHODS      48 
OBSERVATION AND RESULTS      52  
DISCUSSION          89 
SUMMARY         95 
CONCLUSION         97 
ANNEXURE 
      ANNEXURE I        98 
      ANNEXURE II        108 
      ANNEXURE III        111 
      ANNEXURE IV        119 
BIBLIOGRAPHY         
 
 
1 
 
INTRODUCTION 
 Prevention and cure are the basic aims of all system of medicine where as 
the siddha system has in addition the transcendental motivation called the 
immortality of the body.  The basic emphasis of siddha system is on positive 
health i.e to prevent diseases, by careful dieting and proper relaxation of the 
mind to acheive a totality of health that assure only longivity but also 
immortality.  The drug of the siddha system of medicine may be broadly 
classified into herbals, metal and mineral catogories. 
 In siddha medicine the physiological function in the human system is 
mediated by three substances (i) vatham (ii) pitham (iii) kapham.  Which are 
made up of the five elements (i) Mann (ii) Neer (iii) Thee (iv) Vayu and (v) 
Agayam. 
 In the human body the nervous actions which constitude movements, 
activity sensation etc. are due to vatham, the metabolic activity etc. are 
functions of pitham and stability is controlled by kapham. 
 
 If these three thathu function normally, normal health is maintained. The 
normal order of vatham, pitham and kapham are in the proportion of 1: ½ : ¼ 
respectively.  Any change in these proportions will lead to disease. 
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 The post graduate sirappu maruthuvam is a specialized branch in our 
system.  It consists of varmam, Thokkanam, ottradam, yoga and kaya kalpam 
mainly the vadha disease are treated by thokanam and ottradam. 
 
 In India, approximately 68% of the population is affected by “Azhal keel 
vayu” and is more common in post menopausal women. 
 
 It mostly affects the elderly people above 40 years of age.  It produces 
more pain and discomfort in elder people. 
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AIM AND OBJECTIVES 
AIM: 
 To evaluate the therapeutic efficacy of siddha formulation “SAGALA 
VADHA CHOORANAM” (INTERNAL), “ILAGU VADHA KESARI 
THYLAM” (EXTERNAL) in “AZHAL KEEL VAYU” (Osteo arthritis of knee 
joint) for the reduction of pain and swelling and to improve the range of 
movements. 
 
OBJECTIVES: 
1. To study the clinical cause of the disease Azhal keel vayu with keen 
observation on the definition,  Aetiology, pathology, Diagnosis, 
prognosis, complications and the treatment by making use of siddha 
aspects. 
2. To have an idea about the prevalence of Azhal keel vayu with 
reference of Age, sex, family history, occupation, socio ecnomic 
status, diet, habit and climatic conditions. 
3. To know the correlation of aetiology, classification, symptoms, 
diagnosis and line of treatment compared with osteo arthritis of knee. 
4.  To perform the alteration of the disease under the topics of 
Mukkutram, Uyir thathukal, Porigal, Udal thathukal, Envagai 
thervugal, Naadi, Neerkuri, Neikuri. 
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5. To make a clinical trial of patients with the trial medicine SAGALA 
VADHA CHOORANAM (Internal), ILAGU VADHA KESARI 
THYLAM (External) in the treatment of Azhal keel vayu. 
6. To use of modern parameters in the investigation of X-ray to confirm 
the diagnosis and to follow the progression of patients. 
7. To elicit the Biochemical analysis and Pharmacological action of the 
trial medicine. 
8. To insist Thokkanam, Ottradam, Asanam exercise along with 
medicine to acheive the good results, which are the salient features of 
Sirappu Maruthuvam. 
5 
 
REVIEW OF LITERATURE 
SIDDHA ASPECT 
 In siddha system the disease are due to the variation of thrithathu namely 
vatham, pitham, kapham.  Thiruvaluvar says, 
 “kpfpDk; Fiw;;; apDk; Neha; nra;Ak; E}Ny; ; ; ;; ; ; ;; ; ; ; hH 
 tsp Kjyh vz;zpa %d;W; ;; ;; ; ” 
  Vatham , pitham, kapham are called thirithathu in normal condition 
regulate all physiological activities of the human body. 
  When these thirithathu are disturbed and they produce disease. 
fPy; thAP ;P ;P ;  
 In yugi vaidhya sinthamani vadha diseases are classified into 80 types. 
 According to Agasthiyar guna vagadam “keel vayu” comes under the 80 
types of vatha disease.   
“jhdhf fPy;thj Nuhfk; NgiuP ; ;P ; ;P ; ;  
 Neha; jdf;F ghfpaha; thjNuhf nkd;ghH; ; ; ;; ; ; ;; ; ; ;  
 El;gKs;s thjNuhf nkz;gJe; jhd;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 Ma;e;njLj;J ,jw;Fs;N; ; ; ; ;; ; ; ; ;; ; ; ; ; s mlf;fk; ghU; ;; ;; ; ” 
       mfj;jpah; Fzthflk; 
  “Keel vayu” is further divided into 10 types in the text siddha 
maruthuvam according to Saba pathy manucscript. 
 Azhal keel vayu fall in this 10 sub divisions of keel vayu. 
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 “Keel vayu” is the general term that includes all kind of joint diseases.  In 
T.V. Sambasivam Pillai Dictionary “Keel vayu” means mow;rpapdhy; 
nghUj;Jfspy; typiaAk; tPf;fj;ijAk; cz;lhf;Fk; Neha;.  Painful 
inflammation with swelling affecting the muscles and joints of the human body. 
 In Yugi Vaidhya Sinthamani it is mentioned as santhu vadham.  In 
Therayar vagadam it is mentioned as muzhangal vatham, according to affect 
of joints.  In Yakobu Vaidhya Sinthamani it is mentioned as mudakku vatha 
soolai.  In Thanvanthiri Vaidhya Kaviyam it is said as mudakku vatham.   
  In Therayar Vagadam vatham classified into 81 types.  Keel vayu 
comes under the classification of 81 types of vatham. 
  
thjk;:;;;  
,Ug;gplk;:; ;; ;; ;  
 tspKjyh naz;zpaKf; Fw;w nky;yhk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 tho;tnjDk; NjfKw;Wk; gk;gpgue;J; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 njspTwr; rhw;Wk; ehgpf; F; ; ; ;; ; ; ;; ; ; ; f;fPo; thjk;; P ; ;; P ; ;; P ; ; 
kUj;Jt jdpg;ghly; 
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nghUs;:;;;  
 thjk; Kjyhf vz;zg;gl;l Kf;Fw;wq;fs; cly; Kw;Wk; gutp 
tho;git vdpDk; tsp nfhg;GOf;F fPo; cs;sJ. 
 “nespe;jpl;l thjkgh dj;ijg; gw;wp; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 epiwe;jpiliar; Nrh;e;Je;jpf; fPNo epd;W; ; ; ; ; ; P ;; ; ; ; ; ; P ;; ; ; ; ; ; P ;  
 Fspe;jpl;l %ykJ nlOe;J fhkf;; ; ; ;; ; ; ;; ; ; ; 
 nfhbapiliag; ;;; gw;wpnaOq; Fzj;ijg; ghNu; ; ; ;; ; ; ;; ; ; ;  
 Fzkhd ntYk;igNkw; nwhf;if ehb; ; ;; ; ;; ; ;  
 ------------ 
 epzkhd nghUj;jplKk; Nuhkf; fhYk;; ; ; ;; ; ; ;; ; ; ; 
 epiwthfp khq;fprnky; yhk;gue;J; ; ; ;; ; ; ;; ; ; ;  
 ----------------- 
 ----------------- 
 fhy;fhl;b thjnkq;Fq; fyf;Fe; jhNd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; ” 
     - jkpo; kUj;Jt tapj;jpa rjfk;. 
nghUs;:;;;  
 tspahdJ> mghdd;> kyk;> ,lfiy> re;jpapd; fPo; %yk;> 
fhkf;nfhb> ,Lg;G> vYk;G> Njhy; euk;Gf; $l;lk;> fPy;fs;> kaph;f;fhy;> 
Cz; vd;Dk; ,lq;fspy; tho;tjhFk;. 
 “ehnkd;w thjj;Jf; fpUg;gplNk Nfsha;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 ehgpf;Ff; fPnod;W etpy yhFk;; ; P ; ;; ; P ; ;; ; P ; ;”    -A+fp Kdp 
nghUs;;;; 
 kyKk;> ehgpf;F fPoplKk; thjkpUf;Fk; ,lq;fs; MFk;. 
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 “mwpe;jpLk; thj klq;F kyj;jpdhy;; ; ; ; ;; ; ; ; ;; ; ; ; ;” 
 thjk; kyj;jpy; mlq;Fk; vd jpU%yh;;;; $wpAs;shH. 
thjk; nghJf;Fzk;:; ; ;; ; ;; ; ;  
 “tspapd; gz;G nefpo;r;rp guty;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 twl;rp tpiujy; jl;gk; El;gk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;” 
   - kUj;Jt jdpg;ghly; 
nghUs;;;; 
 thjj;jpd; Fzq;fs; nefpo;r;rp> guTjy;> twl;rp tpiuthf ,lk;tpl;L 
,lk; Nghjy; jz;nzd;wpUj;jy; Ez;zpajha; ,Uj;jy; vd;gdthFk;. 
 
thj Neha;fspd; ,ay;G; ; ;; ; ;; ; ;  
 thjtPW md;d kpwq;fhJ fLg;Gz;lhFk; tz;z Kz;lhFk;P ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ; 
 NkhJ fl;LNuhfk; RuKz;lh kpUkYkh Kwq;fh njd;Wk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 XJ #hpa thjkdNyhL eLf;fKz;lhk; nghUs; fsh; ; ; ;; ; ; ;; ; ; ; a;j;; ;; ;; ; 
 jP njdNt euk;gprpj;J re;Jfs; NjhWq; fLf;Fe; jpdKe; jpNdP ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ;  
       - Njiuah; thflk; 
nghUs;;;; 
 thjtPWs;s NghJ czT nry;yhJ> clypy; fLg;G cz;lhFk;.  
cly; epwk; Vw;gLk;> RuKk; ,UkYk; cz;lhFk;. cwf;fk; nfhs;shJ.  
thj Nehapy; cly; mdy; Nghy; fhAk;.  eLf;fk; fhZk;> euk;gprpT 
fhZk; vd;gpd; %l;nfspy; typ fhZk;. 
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thjk; mjpfhpj;jjpd; FwpFzk;:; ; ; ;; ; ; ;; ; ; ;  
 “Nktpa thjQ;nra;Aq; Fze;jid tpsk;gf; Nfsha;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 jhtpa tapWke;jQ; re;Jfhy; nghUj;J Nehthe;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 Nrtpa jhJehrQ; Nrh;j;JePHf; fLj;J tPOk; ; ; ; P ; ; P ;; ; ; P ; ; P ;; ; ; P ; ; P ;  
MjpahDiuj;j ghd;ik NtjkhNk; ;; ;; ; ” 
      jd;te;jphp itj;jpak; 
 
nghUs;:;;;  
 thjk; mjpfkhdhy;> tapW ke;jk;> re;J> fhy; nghUj;J NehT> 
jhJehrk;> ePHfLg;G Mfpa FwpFzk; cz;lhFk;. 
 
thjk; kpFjpahy; tUk; FwpFzq;fs;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 mwpatpk; %d;wd; jhz;ik nrhd;dhH ee;jp 
 vwpaey; thj nkwpf;Fq;Fzq; NfS 
 Fwpnazf; iffhy; Fsr;Rtpyhr; re;J; ; ; ;; ; ; ;; ; ; ;  
 gwpnad nehe;Jlw; gr;irg;Gz; zhFNk 
      - jpU%yh; 
thjk; mjpfhpj;jhy; if> fhy;> Fsr;R> tpyhr; re;J Mfpa nghUj;Jfs; 
typ cz;lhfp gr;ir Gz; Nghy; NehTz;lhFk;. 
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 “fhzg;gh thj Kwpy; 
 fhy;iffs; nghUe;jp; ; ;; ; ;; ; ;  NehFk; 
 G+zg;gh Fly; Gul;Lk; 
 kyQ;ryk; nghUkpf; fl;Lk; 
 Czg;gh FspUq; fha;r;ry; 
 clk;ngy;yhq; Fj;Jk; tha;T 
 tPzg;gh Fj kpWf;Fk; 
 tpah;itAk; Nth;f;Fe; jhNd” 
     fhtpaj;jpd; ehb 
thjk; mjpfhpj;jhy;; ; ;; ; ;; ; ; 
 fhy; iffs; nghUj;Jfs; NehFk;> Fly; Gul;Lk;> kyk;> ryk; 
Fiwe;J fl;Lk;.  Fsph; fha;r;ry; cz;lhFk;. clk;ngy;yhk; Fj;Jk;.  
Fjk; ,Wf;Fk;> tpah;it Mfpa FwpFzk; fhl;Lk; 
 
Neha; tUk; top; ;; ;; ;   
  czthjp nray;fs;> md;whl gof;ftof;fq;fs;> MkNjhlk;> 
Rw;Wg;Gw  #o;epiyfs; Mfpait caph; jhJf;fspy; khWghL Vw;gLj;jp 
Nehia cz;lhf;Fk;. 
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Environmental factor 
 thjthj; jidfhy NkNjh ntd;dpy;; ; ;; ; ;; ; ; 
  kUTfpd;w thdpfh;f; flf khFk;; ; ; ;; ; ; ;; ; ; ; 
 Mjitg; grpNahL fhHj;jpif jd;dpy;; ; ; ;; ; ; ;; ; ; ; 
  mlUNk kw;wkh jq;fs; jd;dpy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 NghjNt rkpf;Ffpd;w fhykhFk;; ; ;; ; ;; ; ; 
  nghUe;jpNa ,th;njhopy; jhd; fz;jpwj;jy;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 fhjNt fz;%ly; iffhy irj;jy;; ; ; ;; ; ; ;; ; ; ; 
  fbe;Njhl;l Klf;fnyhL ePl;l nyz;Nz; ; ; P ; ;; ; ; P ; ;; ; ; P ; ;  
- A+fp itj;jpa rpe;jhkzp 
nghUs; 
 thjk; jd;dpiyapy; rpwg;GWk; khjq;fs; flf Kjy; Jyhk; 
mjhtJ Mdp Kjy; fhHj;jpif MFk;.  ,jd; njhopy; fz;jpwj;jy;> 
fz;%ly;> iffhy; mirj;jy;> klf;fy;> ePl;ly; vd;gd thFk;. 
 
 flfKjy; Jyhk;tiuAk; thj khFk;; ; ; ;; ; ; ;; ; ; ; 
  fz;zhb iag; grpA kJNtahFk;; ; ;; ; ;; ; ;”. 
- gjhHj;j Fz rpe;jhkzp 
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Physical factor 
 jhndd;w frg;NghL Jth;g;G iwg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 rhjfkha; kpQ;RfpYk; rikj;j td;dk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 Mndd;w thwpdJ Grpj;j yhYk;; ; ;; ; ;; ; ; 
 Mfhaj; NjwyJ Fbj;j yhYk;; ; ;; ; ;; ; ; 
 ghndd;w gfYwf;f kpuhtp opg;G; ; ;; ; ;; ; ;  
 gl;bdpNa kpfTWjy; ghunka;jy;; ; ; ;; ; ; ;; ; ; ; 
 Njndd;w nkhopahH Nkw; rpe;ijahjy;; ; ; ;; ; ; ;; ; ; ; 
 rPf;fpukha; thjkJ nrdpf;FeP ; ; ;P ; ; ;P ; ; ; ; jhNd;;;  
- A+fp itj;jpa rpe;jhkzp 
 
 frg;G> Jth;g;G> cg;G Mfpa Ritfs; mjpfhpj;jjhYk;> Mwpd 
md;dk; cz;gjhYk;> gfYwf;fk;> ,uT tpopj;jy;> gl;bdp> ngz;fs; Nky; 
mjpf ,r;irnfhs;sy; Mfpa fhuzq;fshy; thjk; mjpfhpf;Fk;. 
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fPy;thAP ;P ;P ;  
NtWngah;fs; :  ; ;; ;; ;  
  re;Jtyp> %l;Ltyp>  Klf;F thA>  Mkthjk; vd;gd 
• fPy;fspy; tspf;Fw;wk; $b Nehia cz;lhf;Ftjhy; 
fPy;thAnadTkP ;P ;P ; ;>  
• %l;Lfspy; Nehia cz;lhf;Ftjhy; %l;Ltyp;;;  vd;Wk;>  
• G+l;Lfis Klf;fp itg;gjhy; Klf;F thA;;;  vd;Wk;>  
• tapw;wpy; ke;jk; cz;lhfp Iaj;ijg; ngUf;fp ,e;Neha; 
cz;lhtjhy; Mkthjk;;;; vdTk; ngah; ngw;wJ 
 
,ay;G: ;;;  
  fPy;fspy; tPq;FtJ> Fj;JtJ> NehtJ Kjypatw;iw cz;lhf;fp> 
klf;fTk;> ePl;lTk;> mirf;fTk; xl;lhkw; nra;J gLf;ifapy; ,Uj;jp> 
IaKk; $b Ruk; Kjypa Jiz Neha;fisAk; cz;lhf;Fk; 
,ay;GilajhFk; ,jid fPo;fz;l ghlyhy; mwpayhk; 
 
  “tspA ikAe; jd;dpiy nf; ;; ;; ; l;L;;;  
 typAld; tPf;fr; RuKk; fha;e;J; P ; ; ; ; ;; P ; ; ; ; ;; P ; ; ; ; ;  
 %l;Lf;  NlhWk; KLf;fpNa nehe;J ; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 %l;Lf ld;dpd; ePUk; Rue;J; ; ; P ; ;; ; ; P ; ;; ; ; P ; ;  
 jhq;nfhzh typAld; nehe;jpL kk;Nk; ; ; ;; ; ; ;; ; ; ; ”    
- rghgjp ifNaL   
 
 Neha; tUk; top; ;; ;; ;  
  “tspjU fha;fp oq;F; ;; ;; ;  
  tiutpyh Japyy; Nfhio;;;  
 Kspjaph; Nghd;kp Uf;F; ; ;; ; ;; ; ;  
  Kiwapyh Tz;b Nfhly;; ;; ;; ; 
 Fsph;jU tspapw; Nwfq;; ; ;; ; ;; ; ; 
  Fdpg;Gw Tyty; ngz;bh;; ; ; ;; ; ; ;; ; ; ; 
 fspj;jU Kaf;fk; ngw;Nwhh;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  fbnray; fUtpahkhy;; ;; ;; ;”  rghgjp ifNaL 
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nghUs; :;;;  
• tspf; Fw;wj;ijj; J}z;Lk; czTfshfpa thiof;fha;> 
cUisf;fpoq;F> Kjypa nghUs;fisAk;> nray;fisAk;. 
• Fsph;r;rp jUk; nghUs;fisAk; cz;gjhYk; 
• Fsph; fhw;wpypLgly; 
• kioapy; eidjy; 
• gdp thilapy; gLj;jpUj;jy; 
• cah;e;j kiyapy; jq;Fjy; Mfpaitfshy; ,e;Neha; gpwf;Fk; 
• md;wpAk;> ngz; $l;lhy; gpwe;j Nkf Neha;f;F JizahAk; 
• jha; je;ijahpd; topahfTk; tUtJz;L 
 
 
taJ 
czT 
gof;ftof;fq;fs;> 
fhy khWghL 
 
  
thjk; gpj;jk; fgk; 
rhjfk; tpahdd; 
mghdd; 
rkhdd; 
re;jpfk; 
moy;fPy;thA 
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tiffs; :;;;  
fPy;thA gj;J tifg;gLk; mit 
1. tspf;fPy;thA 
2. moy; fPy; thA 
3. Iaf;fPy;thA 
4. tspj;jpf;fPy;thA 
5. tspIaf;fPy;thA 
6. jPtspf; fPy;thA 
7. jP Iaf;fPy;thA 
8. Iatspf; fPy;thA 
9. Iaj;jpf; fPy;thA 
10. Kf;Fw;wf;fPy;thA vd;gd thFk; 
 
moy;fPy;thA; P ;; P ;; P ;  
FwpFzq;fs;: 
  “gpj;jf;f; ;; ;; ; PP PPy; thA;T jd;dhw;; ; ; ;; ; ; ;; ; ; ; 
 gpwq;FfPd; %l;L tPq;fpr; ; P ; ; P ; ;; P ; ; P ; ;; P ; ; P ; ;  
 rpj;jh;nr; ;; ;; ; a; kUe;J tj;Jf;; ; ; ;; ; ; ;; ; ; ; 
 rPh;glhj; jd;ikj; jhfpj;P ; ; ; ; ;P ; ; ; ; ;P ; ; ; ; ; 
 jj;jW fha;r;ry; fz;L; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 rhyNt jidjhd; je;Nj; ;; ;; ;  
 nkj;jW rpfpr;ir jd;dhy; ; ; ; ;; ; ; ;; ; ; ;  
 nkd;Nky; ePq;F kg;gh; ; P ; ;; ; P ; ;; ; P ; ; ” 
    - rghgjp ifNaL 
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nghUs;:;;;  
  ,J tspf;Fw;wk; jd;dpiyapy; kpFe;Js;s NghJ moy; Fw;wj;ijj; 
J}z;lf;$ba czT nra;if Kjypatw;why; gpwf;Fk; NehahFk;. 
,e;Nehapy;> Kl;bfspy; cz;lhFk; tPf;fk; ehSf;F ehs; ngUj;Jf; 
nfhz;Nl te;J> kpFe;j jPf;Fw;wj;jhy; fPy;fspilNaAs;s gir twz;L 
giraw;Wf; fPy; mirAk; Nghnjy;yhk; el;ilAiljYk;  “fYf;” “fYf;” 
nfd;w Xh; xyp cz;lhtJkha; ,Uf;Fk; rpyNtisfspy; fPYf;Ff; fPy; 
$b xl;bf; nfhz;L> klf;f KbahkNy epd;W tpLtJk; cz;L 
,e;Neha;f;F rpW RuKk; tUk;. 
 
SIGNS AND SYMPTOMS 
 
 It is characterized by swelling of joints associated with severe pain.  
Since it is not quickly responding to medicine.  The prolonged and proper 
medical care is said to be essential. 
 
DIAGNOSIS IN SIDDHA 
caph; jhJf;fs;:; ; ;; ; ;; ; ;  
Kf;Fw;w NtWghL; ;; ;; ;  
thjk;;;; njhopy;;;; 
moy;fPy; ; P ;; P ;; P ; thAtpy; ;;;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
gpuhzd; %r;R thq;fy; tpLjy; nra;Ak; ,ay;G 
mghdd; fPo;Nehf;fp kyj;ijj; js;Sk; ghjpg;G (kyf;fl;L) 
tpahdd; 
cWg;Gfis ePl;b klf;f 
nra;Ak; 
ghjpg;G (fhy;fis ePl;b 
klf;Ftjpy; rpukk;) 
cjhdd; 
cztpd; rhuj;ij clypy; 
epWj;Jk; 
,ay;G 
rkhdd; kw;w thAf;fis rhpg;gLj;Jk; 
ghjpg;G (kw;w thAf;fs; 
ghjpg;G) 
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ehfd; 
vy;yh fiyAk; fw;Fk; gb 
nra;jy; 
,ay;G 
$Hkd; 
fz;fis jpwf;fTk; %lTk; 
nra;Ak; 
,ay;G 
fpUfud; 
ehtpw; frpitAk; ehrpapw; 
frpitAk; cz;lhf;Fk; 
,ay;G 
Njtjj;jd; 
Nrhk;gy;> cly; Khpj;jy; 
cz;lhFk; 
,ay;G 
jdQ;nrad; 
,we;j gpd; %d;whk; ehs; 
jiyntbj;J ntspNaWk; 
- 
 
t.vz;;;; gpj;jk; ; ;; ;; ;  njhopy;;;; 
moy;fPy; ; P ;; P ;; P ; thAtpy; ;;;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1 mdw;gpj;jk; 
cz;l czT nghUis 
nrhpf;Fk;gb nra;Ak; 
,ay;G 
2 ,uQ;rfk; nre;ePiu kpFjpgLj;Jk; ,ay;G 
3 
rhjf 
gpj;jk; 
tpUg;gkhd njhopiy nra;J 
Kbf;Fk; 
ghjpg;G (njhopy; 
nra;a rpukk;) 
4 
MNyhrf 
gpj;jk; 
fz;fSf;F nghUis 
njhptpf;Fk; 
,ay;G 
5 
gpuhrf 
gpj;jk; 
NjhYf;F xypia nfhLf;Fk; ,ay;G 
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t.vz;;;; fgk;;;; njhopy;;;; 
moy;fPy; ; P ;; P ;; P ; thAtpy; ;;;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1 mtyk;gfk; 
kw;w ehd;F Iaq;fSf;Fk; 
gw;W NfhlhapUf;Fk; 
ghjpg;G 
2 fpNyjfk; nrhpj;jy; ,ay;G 
3 Nghjfk; Ritia mjpfhpf;Fk; ,ay;G 
4 jw;gfk; fz;fSf;F Fsph;r;rp ,ay;G 
5 re;jpfk; 
fPy;fspy; epd;W ,aw;ifaha; 
vy;yhf; fPy;fisAk; 
xd;Nwhnlhd;W nghUj;jp 
jsu nra;Ak;. 
ghjpg;G (fPy;fspy; 
ePl;b klf;f rpukk;). 
 
  In “Azhal keel vayu”, the vadha kuttram is mainly affected followed by 
pitham and kabam. 
  When the vadha dosham is in vitiated condition ,activity and dietary 
habits provoke the pitha dosam and derange the kapham.  
  The normal structural quality of the pitham is  
• Heat (ntg;gk;) 
• Sharpness ($h;ik) 
• Lubrication (nea;g;G) 
• Relaxation (nefpo;r;rp) 
• Motion (,af;fk;) 
 
 In Azal keel vayu the deranged  pitham may produce stiffness, restriction 
of movements in the affected joints. 
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  The normal structural quality of Kapham is  
• nea;g;G (Lubrication) 
• tOtOg;G>  
• nkd;ik 
  In Azal keel vayu the deranged kapham may produce decreased secretion 
of synovial fluid may lead to loss of lubrication resulting in crepitation of joints. 
 
Kf;Fw;w NtWghL:; ;; ;; ;  
  tspkpF tghd tpahd 
  thAf;f sjpf hpf;Fk;; ; ;; ; ;; ; ; 
 ,skpf kyePh;f; fl;Lk;P ; ; ; ;P ; ; ; ;P ; ; ; ; 
  ,ak;gpa tghdd; nra;Ak;; ; ; ;; ; ; ;; ; ; ; 
 tpsptpyh tpahdd; fPypd;; P ;; P ;; P ; 
  tpsq;FW Giof NlhWk;; ;; ;; ; 
 xspAW Fw;w nky;yh; ;; ;; ;  
  nkhd;wpnyd; Wytr; nra;A; ; ; ;; ; ; ;; ; ; ; k; ;;;  
 
rghgjp ifNaL 
 
t.vz;;;; 
cly; ;;;
jhJf;fs;; ;; ;; ; 
njhopy;;;; 
moy;fPy; ; P ;; P ;; P ; thAtpy; ;;;
fhzg;gLtJ;;;  
1 rhuk; 
cliyAk; kdijAk; 
Cf;fKwr; nra;tJ  
ghjpg;G (cly;Nrhh;T> 
kdNrhh;T) 
2. nre;ePh; 
mwpT> td;ik> xsp> nrUf;F 
,itfis epiyf;f 
nra;tJ 
,ay;G 
3. Cz; 
clypd; cUtj;ij 
mikj;jYk;> vd;ig 
tsh;j;jYk; 
ghjpg;G (tPf;fk; 
fhzg;gly;> Cz; 
Fiwjy;) 
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4. nfhOg;G 
cWg;Gfs; ,aq;f mtw;wpw;F 
nea;g;Ggir Cl;LtJ 
ghjpg;G (fPy;fspy; 
nea;g;G gir 
Fiwjy;) 
5. vYk;G 
cly; mirtpw;F 
mbg;gilahapUj;jy; 
ghjpg;G (vd;Ggyk; 
Fiwjy;) 
6. %is 
vd;Gf;Fs; epiwe;J 
td;ikAk;> nkd;ikAk; 
jUtJ 
ghjpg;G 
7. ntz;zPh; 
fU Njhw;wj;jpw;F Kjyha; 
epw;gJ  
,ay;G 
 
 
vz; tif Njh;T; ;; ;; ;  
 “ehb ];ghprk; eh epwk; nkhop tpop; ; ;; ; ;; ; ;  
 kyk; %j;jpukpit kUj;JtuhAjk;; ; ; ;; ; ; ;; ; ; ;” 
   - Neha; ehly; Neha; Kjy; ehly; (Kjy; ghfk;) 
 
 
1. ehb :  
 
  “thjj;jpy; Nrj;Jk khfpy; typNahL tPf;f Kz;lhk;; ; ; ; P ; ; ;; ; ; ; P ; ; ;; ; ; ; P ; ; ;” 
       mfj;jpah; ehb 
 
“mwpe;Jghh; thjNk jdpj;jhdhy;; ; ; ;; ; ; ;; ; ; ; 
 rhpe;jplNt fhy;Klf;Fk;; ; ; ;; ; ; ;; ; ; ;” 
 
       mfj;jpah; uj;jpd RUf;fk; 
 
 “fhzg;gh thj kPwpy; fhy;iffs; nghUe;jp Neh; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; Fk;;;;” 
       fhtpaehb 
  thjk;>  thjgpj;jk;> gpj;j thjk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
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2. ];ghprk;; ;; ;; ; :  ghjpf;fg;gl;Ls;s %l;L gFjpapy; kpj ntg;gkhfNth> 
,ay;ghfNth fhzg;gLk; 
 
3. eh: ,ay;G>  thjNehapy; eh jbj;J ,Uf;Fk; 
 
4. epwk;: ;;; ,ay;G> khepwk; 
 
5. nkhop :  rkxyp 
 
6. tpop :  ,ay;G> thj Nehapy; tpop fWj;J ,ik jbj;jpUf;Fk; 
 
7. kyk;:;;;   ghjpg;G (kyrpf;fy; fhzg;gLk;) 
 
8. %j;jpuk;; ;; ;; ; :  %j;jpuk; fLg;Gld; nfhQ;rkhf EiuAld; ,wq;Fk; 
 
nea;f;Fwp ; ;; ;; ;  
 
“mUe;J khwpujKk; mtpNuhjkjha;; ; ;; ; ;; ; ; 
m‡fy; myh;jy; mfhyT+d; jtph;e;jow;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
Fw;wstUe;jp cwq;fp itfiw; ; ;; ; ;; ; ;  
Mbf;fyrj; jhtpNa fhJ nga;; ; ;; ; ;; ; ; 
njhUK$h;j;jf; fiyf;Fl;gL ePhpd;; ; ; ; ; P ;; ; ; ; ; P ;; ; ; ; ; P ; 
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
 
 
  Prior to the day of urine examination the patient is instructed to take a 
balanced diet and quantities of food must be proportionate to his routine  intake.  
 
  The patient could have no disturbed sleep. After waking up in the 
morning the first urine voided is collected in a clear wide mouthed glass 
container and is subjected to analysis of  “Neerkuri and Neikkuri” within one 
and a half an hour. 
 
  The collected specimen was examined by the following method. The 
collected urine specimen is kept in a glass container and observed under direct 
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sunlight without shaking the vessel. Then drip one drop of gingelly oil and 
observe the spreading pattern and concludes as follows. 
 
“muntd ePz;bdNf thjk;P ; ;P ; ;P ; ;” 
“Mop Nghw;gutpd; m; ;; ;; ; ‡Nj gpj;jk;; ;; ;; ;” 
“Kj;njhj;J epw;fpd; nkhoptnjd; fgNk; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
“mwtpyhopAk; Mopapy;; ;; ;; ; muTk;;;; 
mutpd; Kj;Jk; Mopapy; Kj;Jk; ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
Njhw;wpy;  njhe;j Njhlq;fshNk; ; ; ;; ; ; ;; ; ; ; ” 
 
ePh;f;Fwp:P ; ;P ; ;P ; ;  
 
“te;j ePHf;fhp vil kzk; Eiu vQ;rnyd;; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; 
iwe;jpaYstit aiwFJ KiwNa;;; ” 
 
epwk; (Colour) 
vil (Specific Gravity) 
kzk; (Smell) 
Eiu (Frothy nature) 
vQ;ry; (Quantity of urine voided) 
 
thj Nehapy;> 
 
 “Xq;fpa thjj;NjhHf;F ePHtpOq; FzKiwf;fpw;; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ; 
 G+q;nfhb fLj;Jnehe;J rpWj;Jld; nghUkp tpOk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;” 
 
gUt fhyq;fs;: ; ;; ;; ; (Seasonal variations) 
Fw;wk;; ;; ;; ;     fhyk;;;; 
thjk; - jd;dpiy tsh;r;rp  KJNtdpw;fhyk; 
thjk; - Ntw;Wepiy tsh;r;rp  fhHfhyk; 
thjk; - jd;dpiyailjy;  $jph;fhyk; 
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 thjj;jpd; ,aw;if Fzk; twl;rp> KJNtdpw; fhyj;jpYk; twl;rp 
Vw;gLtjhy; thjNeha; mjpfhpf;fpwJ. 
 
jpiz: (Geographical distribution) 
thj Neha; Vw;gLk; epyq;fs; 
  Ky;iy - fhLk; fhL rhHe;j gFjpAk; 
    thj rhHghd gy Neha;fs; cz;lhFk; 
nea;jy; - flYk; fly; rhHe;j ,lKk; 
    ,e;epyj;jpy; nfhLikahd thjNeha;fNs  
cz;lhFk;. 
ghiy - kzYk; kzy; rhHe;j gFjpAk; 
ghiyepyk; thjk;> gpj;jk;> fgk; ,tw;why;>  
tpisfpd;w gpzpfl;F ,Ug;gplk; MFk;. 
 
Neha; fzpg;G tpthjk; (; ; ;; ; ;; ; ; DIFFERENTIAL DIAGNOSIS) 
1. tspf;fPy; thA; P ;; P ;; P ;  
 typf;Fj;jy; tPf;fq; ; ; P ;; ; ; P ;; ; ; P ; ; fhZk; tha;njhz;il> twl;rp fha;r;ry;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 jiytyp khHJ bg;Gj; jhq;nfhzh typtPf; fe;jhd;; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ; 
 epyTfhw; fZf;F wq;F ePLNjhs; Koq;iff; fhw;fhk;; ; ; P ; ; ; ; ;; ; ; P ; ; ; ; ;; ; ; P ; ; ; ; ; 
 kyf;Flw; fl;L Nth;it thjj;jpy; tha;tp jhNk.; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
rghgjp ifNaL 
 
  It is characterized by execruciating pain and swelling knee joints, hip 
joints, ankle joints, shoulder joints, elbow joints and associated with dryness of 
mouth, pyrexia, Head ache, palpitation, constipation and sweating. 
 
2. Iaf; fPy;thA; P ;; P ;; P ;  
 “fUjUq; fgf;fPy;thA fz;bd; clypisf;Fk;; ; P ; ; ; ; ;; ; P ; ; ; ; ;; ; P ; ; ; ; ; 
 cUnkyp thf;Fq; nfhs;Sk; cz;biar; RUf;Fk; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; ; ,d;ge;; ; ;; ; ;; ; ; 
 jUJapy; ePq;F Kl;bw; whq; nfhzh tYit ahf;Fk;; P ; ; ; ; ; ;; P ; ; ; ; ; ;; P ; ; ; ; ; ; 
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 ,UkNy tpf;fy; the;jp Nrhigghz; nlOg;Gk; ghNu; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; ” 
      - rghgjp ifNaL. 
 It is characterized by loss of weight. Anorexia, severe pain in the knee 
joint, insomnia, cough, hiccough, vomiting, anaemia and dropsy.  The common 
site are vertebrae, hip joint, knee joint. 
 
3. tsp Iaf;fPy; thA; P ;; P ;; P ;  
 “taq;th jf;f gf;fpy; thAthd; typkp Ue;jNj; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 caq;FePH Nfhj;Jf; fPy;fs; Xhpapd; jiyNghw; fhZk;; P ; ; P ; ; ; ; ;; P ; ; P ; ; ; ; ;; P ; ; P ; ; ; ; ; 
 eaq;nfhs;s Klf;fy; ePl;ly; ez;zplh nka;Aq; fhAk;; ; ; ; P ; ; ; ; ; ;; ; ; ; P ; ; ; ; ; ;; ; ; ; P ; ; ; ; ; ; 
 kaq;FW Kwf;f kpd;dha; kd;dpa; ; ; ; ;; ; ; ; ;; ; ; ; ;  nehpf;fl; lhNk; ;; ;; ; ” 
 
 It is characterized by pain in the joints and effusions of joint fluid, 
swelling, restricted joint movements, pyrexia, fainting, insomnia, lymph 
adenopathy.  The affected joints look like “Fox’s Head” ;. 
 
AIMS OF TREATMENT OF OA KNEE: 
• Relieve pain 
• Restore function 
• Reduce disability if any  
• Rehabilitation 
 
 
LINE OF TREATMENT 
 The treatment of Siddha system includes not only the removal of signs 
and syptoms of a disease but also in total uprootment of the diseases. 
 In Azhal keel vaayu the deranged vatham is brought to its normal state by 
purgation  
 
 “tpNurdj;jhy; thjk; jhO; ; ;; ; ;; ; ; k;; ;;” 
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1. 15ml of vellai ennai is given with warm water early morning (single dose) in 
empty stomach before starting the treatment with trial drug. 
 
2. Internal medicine 
 Sagala vadha chooranam-1.5gm three times/day given with water after 
food. 
 
 
3. External medicine 
Ilagu vadha kesari thylam - External application. 
  Apart from other department, sirappu maruthuvam department gives 
equal important to external therapy in siddha system of medicine along with its 
internal and external medicines. 
 
EXTERNAL THERAPIES: 
 They are kattu, pattru, vaedhu, puravalayam, Thokkanam, ottradam, 
varmam, asanam etc., 
 
1. fl;L (;;; Bandage) 
 Kattu is the application of medicine made of herbs, to the affected area 
and bandaged. 
 
Herbals: 
 Vitex negundo (nehr;rp) 
 Justicia beddomei (MlhNjhil) 
 Clerodendrum phlomoidis (thjklf;fp) 
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Procedure: 
 These plants leaves are made into small pieces and it is mixed with 
external oil and it is spread in a piece of cotton which is wrapped along the 
affected joint and bandaged with dressing cloth. 
Use: 
 It is used in the condition of acute swelling and pain in osteoarthritis of 
knee joint. 
 
2.njhf;fzk; ; ;; ;; ; (Massage)  
 
 Thokkanam is one of the 32 forms of external medicines, mentioned in 
ancient siddha literature, improves vadha disease by regulating the vadha 
disturbance. 
 
 It signifies a group of therapeutic procedures usually done with hand on 
the skin of the body in 9 ways, with or without the application of medicated oils 
(Thylam). These procedures can either be curative or palliative. 
   
  “njhf;fzj;jp ; ;; ;; ; dhypuj;je; Njhy;C zpitfl;L; ; ; ;; ; ; ;; ; ; ;  
 kpf;F rTf;fpaQ;r kPuZk;Ngh ; ; ; P ;; ; ; P ;; ; ; P ; - nka;f;fjpf; ;; ;; ;  
 Gl;bAwf;fk; Gzh;r;rp apitfjpf;Fk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 gl;l miyr;r; ;; ;; ; yWk; ghh;; ;; ;; ;” 
      Njud; nghUl;gz;G 
  Theraiyar says that thokkanam. 
 
• Strengthens blood, flesh and skin 
• Improves sleep 
• Vitality and relax whole body 
• Regulates nerve functions, improves blood circulation, 
enhances immunity and removes excess tissues. 
 
  The treatment normally starts with applying the medicated oil on the knee 
joint. 
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Definition: 
  Massage is a term applied to certain manipulations of the soft tissues. 
These manipulations are most efficiently performed with the palmar aspect of 
hand and administered for the purpose of producing effects on the nervous 
system, muscular system as well as on the local and general circulation of the 
blood and lymph. 
 
  Massage is the mechanical stimulation of soft tissues of the body by 
rhythmically applied pressure and stretching. 
 
Sequence of Knee Massage: 
1. Friction 
2. Rounding 
3. Stroking 
4. Rolling 
5. Percussion 
6. Joint movements 
 
Action of Massage: 
  The medicated oil apply to the skin for the purpose of massage penetrate 
through the skin and reach different tissues and other elements of the body. The 
medicated oil used for massage remains in the skin for  300 seconds and then 
gradually spreads to senneer, Oon, Kozhupu, enbu and Moolai. 
 
General effects of massage: 
1. Relaxation 
2. Increased circulation helps to accelerate the lymphatic system, which 
absorbs and eliminates many waste products 
3. Stimulation of sensory and motor nerves 
4. Relief pain and tension 
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Local effects of massage 
1. Local vasodilation 
2. Increase the blood circulation and improves muscle nutrition 
3. Increased joint mobility 
4. Nourishment to the periostium 
5. Absorption of the skin’s waste products 
 
Contra indications: 
Local 
• Recent injuries 
• Recent scar 
• Dislocation 
• Fractures 
• Varicose vein 
• Hyperpyrexia 
• Cancerous tissue 
• Skin diseases 
 
3. xw;wlk; ; ;; ;; ; (Fomentation) 
 Ottradam is the application of hot medicated packs. 
 There are various type of ottradam mentioned in siddha literature.  In this 
study 2 types are used. 
• Hot fomentation by medicated pouches. 
• Hot fomentation by lemon directly. 
 
I . Medicated pouches: 
  Medicated pouches are made up of pieces of leaves. 
• Vitex negundo (nehr;rp) 
• Clerodendrum Phlomoidis  (jOjhio) 
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• Calotropis gigantea (vUf;F) 
• Delonix elata  (thj ehuhazd; ,iy) 
 
rpj;jh; mWit kUj;Jtk; 
Uses : 
• It reduce pain and swelling 
• Increases blood circulation 
 
2. Lemon Ottradam: 
  Lemon is cut into two pieces.  It is then covered by a piece of cloth. The 
cut surface of the lemon piece is dipped into the luke warm gingelly oil and 
applied over the affected parts for 1 hour.  
 
VARMAM ADANGAL: 
  Life energy flows in the body in a particular pathway. There are certain 
key points in the body where this life energy “Vaasi” is concentrated. Normally 
these are the points where two bones joint or a muscle inserts into a bone or the 
blood vessels, nerves are prominent. These points called “Varmam points” 
  The therapy of physical manipulations either by applying pressure on the 
varmam points or using massage therapy with specific medicated oil or blowing 
certain medicines in the nose or ear is called as varmam treatment. 
  Varmams or rhythmically turned by varmam therapists for managing 
various diseases like nervous disorders, arthritis, back pain, spinal problems 
etc., 
  Varmam points to be manipulated for osteoarthrosis are as follows 
 
1. Mootu varmam :  Centre part of posterior apsect of both knee 
joints. Mild pressure is applied using tips of middle three fingers. 
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2. Kuthiraimuga varmam 
Location – Tibial tuberosity  
Pressure is applied for three time using bulb of thumb. 
3. Mootu Suzharchi 
This method stimulates varmam points around knee joint by a 
circulatory gripping massage around patella using thumb and index 
finger. 
4. Santhuvarmam :  
Location : on either side of the mootu varmam 
5. Sirattai varmam :   
Location : on the patella bone. 
6. Mozhi poruthu varmam:  
Location :  Posterior surface of the knee joint  
7. Asaivu thiru kannu varmam: 
Location :  In centre of anterior surface, 2 finger breadth 
sidewards to the knee joint. 
8. Pathaippu Varmam: 
Location :  6 finger breadth lateral to the patella. 
 
YOGASANAM: 
  Yoga therapy is one of the form of relaxing body and mind. Certain 
simple asana techniques are discussed to knee pain and strengthening thigh 
muscle. 
 
Asanam: 
• Vajrasanam 
• Utkatasanam 
• Machasanam 
• Arthamachendrasanam 
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PRANAYAMAM 
 The control of breathing called as pranayama 
 It include three process 
 1.Rechaka– Process of exhalingor breathing out. 
 2. Puraka – Process of inhaling 
 3. Kumbhaka-Process of retaining breath. 
Kumbhaka of two types 
 1.Internal kumbhakam- Act of retaining breath 
 2. External kumbhakam- Action of not breathing in and out. 
Pranayama 
 Pranayama is to yoga  what heart is to human body  
 Pranayama is an important bridge between outward practices of yoga like 
asanas  and inward surrendering yoga practices. It is a link between mind  and 
body. It consist of deepening and extending prana or life force until it leads to 
condition of peace. 
Prana – Life force 
Anayama – control 
Benefit 
 Cause rhythmic expansion  of lungs creating  better circulation within 
kidney, liver, stomach, spleen, intestine,  skin etc., 
 The mind is calm and concentration becomes better. 
 Skin become smother because of better circulation and release of tension. 
 Oxygen is provided for better functioning of heart and lungs. 
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Aims of exercises in osteoarthritis of knee 
• To increase the range of movements. 
• To increase the stability and shock absorption 
• To  prevent deformity 
• To improve posture 
• To reduce pain and stiffness. 
 
Rules of the exercises: 
• Build up the exercises gradually 
• Avoid rough ground while exercising 
• To take warm baths before starting the exercises 
• To perform the exercises 20 times each twice a day and later four times a 
day 
 
 
Conservative measures: 
1. Isometric quadriceps exercise to maintain strength of main stabilizing 
factor of knee. 
2. Avoid movements/ positions which increase patellofemoral pressure. 
Avoid sitting cross legged, climbing status, and squatting positioning. 
3. Use of walking stick held in ipsilateral hand or use of crutches to prevent 
stress on affected knee. 
4. Apply preferably moist heat. Avoid short wave diathermy which is 
destructive 
5. Immobilize the knee by a bandage  
6. Weight reduction by exercise and diet control is advised. 
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MODERN ASPECT 
Osteoarthritis 
 Osteoarthritis, also referred to as degenerative joint disease, 
degenerative arthritis.  Osteoarthrosis or hypertrophic arthritis, is 
among the most frequent and symptomatic medical problems for 
middle aged and older people.  It affects people of all goups in all 
geographic locations, occurs  both in men and women but commonly 
in women, and it is the most common cause of long term disability in 
patient populations older than 65 years.  More than one third of 
people older then 45 years report joint symptoms that vary from a 
sensation of occasional joint stiffness and intermittent aching 
associated with activity to permanent loss of motion and constant 
deep pain.  The joint degeneration that cause the clinical syndrome of 
osteoarthritis occurs most frequently in the hand, foot, knee, hip and 
spine joints, but it can develop in any synovial joint with the 
prevalence of degenerative changes increase with age. 
 Though osteoarthritis affects many joints knee is the most 
common which we come across in our day today practice. 
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ANATOMY OF THE KNEE JOINT 
 
 The knee is the largest and more complex joint of the body.  
Consist of 3 bones and an extensive network of ligaments and 
muscles.  The knee is one of the most important joints of our body.  It 
plays an essential role in locomotion related to carrying the body 
weight in horizontal (Running and walking) and vertical (jumps) 
direction. 
 
Bones of knee joint. 
 The knee joint is complex synovial joint incorporating two 
condylar  joint between the condyles of the femur and tibia. One 
saddle joint between the femur and the patella. 
 The knee joint is  formed by 
1. The condyles of the femur 
2. The patella 
3. The condyles of the tibia. 
 
The knee joint capsule 
 The joint is a thick ligamentous structure that surrounds the 
entire knee.  Inside this capsule is a specialized membrane known as 
the synovial membrane which provides nourishment to all the 
surrounding structures other structures include the infrapatellar fat pad 
and bursa which function as cushion to exterior forces on the knee.  
The capsule is strengthened by the surrounding ligaments. 
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Ligaments of the knee joint 
 The ligaments surrounding the knee  offer stability by limiting 
the movements. 
 Knee joint is supported by following ligaments. 
1. Fibrous capsule 
2. Ligamentum patella 
3. Tibial collateral or medial collateral ligament 
4. Fibular collateral ligament 
5. Oblique popliteal ligament 
6. Arcuate poplitial ligament 
7. Anterior cruciate ligament 
8. Posterior cruciate ligament 
9. Medial meniscus 
10. Lateral meniscus 
11. Transverse ligament 
Bursae around the knee: 
 There are 13 bursae around the knee 
1. Anterior  - 4 
2. Lateral  - 4 
3. Medial - 5 
The largest communicative bursa is the supra patellar bursa. 
 
Menisci 
 Each knee joint has two crescent shaped cartilage menisci.  The 
menisci serve to protect the ends of the bones from rubbing on each 
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other and to effectively deepen the tibial sockets in to which the femur 
attaches.  They also play a role in shock absorption, and may be 
cracked or torn, when the knee is forcefully rotated or bent. 
 
Muscle group  Surrounding the knee joint.  
The two main muscle groups of the knee joint are the quadriceps 
and the  hamstrings.  Both play a vital role, both moving and 
stabilizing the knee joint. 
 
Movements of knee joint 
 Flexion  - 120 - 150 ° 
 Extension  - 0 – 5
o 
 
Blood Supply 
Arteries of the knee 
 The femoral artery and the politeal artery help form the arterial 
network surrounding the knee joint. 
 6 main branches 
1. Superior medial genicular artery 
2. Superior lateral genicular artery 
3. Inferior medial genicular artery 
4. Inferior lateral genicular artery  
5. Descending genicular artery  
6. Recurrent branch of anterior  tibial artery. 
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OSTEO ARTHRITIS 
Definition: 
  Osteoarthritis defined as a degenerative non-inflammatory joint disease 
characterized by destruction of articular cartilage and formation of new bone at 
the joint surfaces and margins. However, it is a misnomer and the right term is 
osteoarthrosis or degenerative joint disease (DJD). 
 
  It results from the rate of degeneration being greater than the rate of 
repair and / or regeneration of articular cartilage. 
 
  By the age of 40 years about 40% of the population have radiographic 
signs of osteoarthrosis of major weight bearing joint and 50% of these will have 
symptoms. 
  Osteoarthritis commonly affects the large weight bearing joint such as 
hips and knees. 
 
Classifications: 
  It could be divided into 2 types 
1. Primary or idiopathic osteoarthritis 
2. Secondary osteoarthritis 
 
Primary osteoarthritis: 
  Primary osteoarthritis is due to the wear and tear changes that occur in 
old age in which weight bearing joints such as hip and knees are more 
commonly affected. 
• Obesity is a predisposing factor 
• Primary osteoarthritis is commoner than secondary osteoarthrosis 
 
(Primary osteoarthritis of the knee (also called idiopathic) 
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Aetiological causes for primary Osteoarthritis: 
• Though exact cause is not known. The following factors are suspected to 
play an important role in causation of primary Osteoarthritis. 
• Obesity 
• Genetics and hereditary 
• Occupation involving prolonged standing. 
• Sports 
• Multiple endocrinal disorder. 
• Multiple metabolic disorders. 
 
Secondary osteoarthritis: 
  Secondary osteoarthrosis refers to arthritis occurring in a joint secondary 
to a previously occurring disease or disorder of the joint. 
 
  It may occur in any age and involve any joint. 
 
 Factors associated with secondary Osteoarthritis are as follows: 
1. Congenital malformation of joints 
2. Traumatic alteration of articular surfaces causing articular 
incongruence. 
3. Loose bodies in the joint 
4. Deforming of the joint 
Eg: Genu varum 
5. Internal derangement of knee 
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Aetiological factors in Osteoarthritis 
1. Geography 
  In a review of Osteoarthritis in 6 population living in different climates, 
as determined by latitude. 
 
2. Racial groups: 
 Prevalence surveys have been carried out in non causasian population. 
 
3. Age 
 Osteo arthritis rises progressively with age such that by 65 years.  80% of 
people have radiographic evidence of Osteoarthritis.  Though only 25-30% are 
symptamatic. 
 
4. Gender 
 The crude prevalence of Osteoarthritis is the same in both sexes, but in 
females more joints are affected.  At age above 45years Osteo arthritis appears 
slightly more frequently in men and involves one or more joints.  At ages 
greater than 55 years Osteoarthritis is more frequent in women and involve 
multiple joints.  It has been shown that Osteoarthritis in post menopausal 
women was associated with higher body weight, higher subcutaneous fat and 
stronger muscles linked to hormonal deficiencies. 
 
5. Socio economic groups 
6. Occupation 
 Occupation with physical activity involve repetitive use of particular joint 
over long period of time.  Sports enthusiasts and professional athelets may be 
conditiond so that their muscles protect their joints, but the manual labourer, 
factory worker may continious to use the joints even after muscular exhausion. 
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7. Obesity 
 Obesity has been associated with increased bone mass major cause of 
Osteo arthritis is the failure of subchondral bone to deform with an impact load, 
leading to increased cartilage damage. 
 
8. Metabolic factors 
 There has been some evidence for a link between Diabetes and Osteo 
arthritis, possibly through elevated growth hormone levels that alter cartilage 
metabolism and increase bone density.  Hyperuricaemia has been found more 
frequently in people with generalized Osteoarthritis. 
 
9. Mechanical factors 
 It has been long considered that mechanical stress, such as single impact 
stress, gross anatomical damage, subtle mechanical derangement (long standing 
internal derangement of the knee) joint, hypermobility and repeated impacts has 
been associated with Osteoarthritis. 
 
Others 
 Nutritional problems  may cause Osteoarthritis  
 
Pathogenesis: 
Normal Articular Cartilage: 
 Articular cartilage is connective tissue covering the ends of the bones. It 
is aneural, alymphatic, avascular structure water and chondrocytes gives 
strength to the articular cartilage. 
 Supremely  adapted to transmit load and movement from one skeletal 
segment to another.  It increases the area of the articular surfaces and helps to 
improve their adaptability and stability; it changes its shape under load and 
distributes compressive forces widely to the subarticular bone and covered by a 
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film of synovial fluid it is more slippery than any man-made material, offering 
very little frictional resistance to movement and surface gliding. 
 This specialized connective tissue has a gel-like matrix consisting of a 
proteoglycan ground substance in which are embedded an architecturally 
structured collagen network and a relatively sparse scattering of specialized 
cells, the chondrocytes, which are responsible for producing all the structural 
components of the tissue.  It has a high water content (60-80%), most of which 
is exchangeable with the synovial fluid. 
 The fibrillar component of articular cartilage is mainly type II collagen.  
The collagen bundles are arranged in structured patterns, parallel to the articular 
surface in the superficial zones and perpendicular to the surface in the deeper 
layers where they anchor the articular cartilage to the subchondral bone. 
 
  Normal cartilage has two main components 
 
i) Extracellular matrix 
ii) Chondrocytes 
 
• Extracellular matrix contain water, collagen (Type II collagen present 90 
– 95%) proteoglycans and non collagenous protein. 
• Condrocytes produce collagen, proteoglycans and enzymes, chondrocyte 
metabolism responds to both mechanical and chemical stimuli 
osteoarthritis is a degenerative condition primarily affecting the articular 
cartilage. 
Articular cartilage changes in Osteoarthritis 
• The earliest changes, while the cartiage is still morphologically intact, 
are an increase in water content of the cartilage and easier extractability 
of the matix proteoglycans.  
• Failure of the internal collagen network that normally restrians the matrix 
gel.  At a slightly later stage there is loss of proteoglycans and defects 
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appear in the cartilage.  As the cartilage becomes less stiff, secondary 
damage to chondrocytes may cause release of cell enzymes and further 
matrix breakdown.  Cartilage deformation may also add to the stress on 
the collogen network, thus amplifying the changes in a cycle that leads to 
tissue breakdown.  
• The levels of certain molecular messengers, including IL-I, TNF and 
nitric oxide are increased in osteoarthritic cartilage. Apoptosis is alos 
increased, likely responsible for a decrease in the number of functional 
chondrocytes. 
• Articular cartilage has an important role in distributing and discipating 
the forces associated with joint loading.  When it loses its integrity these 
forces are increasingly concentrated in the subchondral bone.  The result 
focal trabecular degeneration a cyst formation as well as increased 
vascularity and reactive sclerosis in the zone  of maximal loading. 
• What cartilage remains is still capable of regeneration, repair and 
remodelling.  As the articular surfaces become increasingly malapposed 
and the joint unstable cartilage at the edges of the joint reverts to the 
more youthful activities of growth and endochondral ossification giving 
rise to the bony excrescences, or osteophytes. 
• Articular cartitage does not usually regenerate after injury or diseases 
leading to loss of tissue & formation of a defect. 
• The international cartilage repair society has set up an arthoscopic 
grading system by which cartilage defect can be ranked. 
Grade 0 - (normal) healthy cartilage 
Grade 1 - The cartilage has a soft spot or blisters. 
Grade 2 - Minor tear visible in the cartilage. 
Grade 3 - Lesions have deep crevices (morethan 50%  
of cartilage layer.) 
  Grade 4 - The cartilage tear exposes the underlying  bone. 
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• Articular cartilage has a very limited capacity for self repair.  Small 
damage does not repair itself and can often get worse over time.  
As cartilage is aneural and avascular, shallow damage often does 
not trigger pain. 
• A grade 4 lesion goes completely through all layers of the cartilage.  
It is diagnosed as a full thick ness lesion.  Sometimes part of the 
torn cartilage will break off inside the joint.  Since it is no longer 
attached to the bone, it can begin to more around with in the joint.  
Cartilage even more damage to the surface of the cartilage.  This 
unattached piece as a loose body. 
 
PATHOLOGY 
 The cardinal features are:  
1. Progressive cartilage destruction 
2. Subarticular cyst formation 
3. Sclerosis of the surrounding bone 
4. Osteophyte formation 
5. Capsular fibrosis. 
• The first change observed is an increase in water content and depletion of 
the proteoglycans from the cartilage matrix. Repeated weight bearing on 
such a cartilage leads to fibrilation. 
• The cartilage gets abraded by the grinding mechanism at work at the 
points of contact between the apposing articular surfaces, until eventually 
the underlying bone is exposed  with further  “rubbing”  the subchondral 
bone becomes hard and glossy  (eburnated) 
• Subchondral sclerosis and subchondral cysts are seen. 
• Bony projections and new bone formation (osteophytes) occur within the 
joints 
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• Thickening of the joint capsule and synovium leads to stiffness and 
deformity of the joint 
• In the knee medial compartment is affected more than the lateral leading 
to a varus deforming (Genu varum) 
 
Signs and Symptoms: 
  The patient presents with  
• Pain that starts insidiously and increase overtime 
• Swelling – as a result of joint effusion 
• Morning stiffness, which usually lasts no more than 30 minutes. 
• Stiffness from the thickening of capsule and synovium 
• Crepitus  - While moving the joint 
• Limping  - due to pain and deformity of the joint 
• Tenderness 
• Restricted range of joint movements. 
 
Examination of knee joints: 
• The patient should be examined in the lying down position. First in 
supine position and then in prone position 
• Always compare the affected knee with the opposite normal knee 
 
INSPECTION: 
1. Gait: Recurvatum deformity can be best appreciated when the patient 
walks. A patient with weakness of the quadriceps muscles may walk with  
“hand knee gait”. 
2. Skin colour -  If acute Osteoarthritis redness present due to 
inflammation (Swelling)  
3. Swelling : Mild Swelling present around the knee joint 
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4. Deformity: Varus deformity present. Flexion deformity is the 
commonest.  Initially, it occurs due to spasm of the hamstring muscles in 
any painful conditions of the knee. 
5. Muscle wasting: Quadriceps muscle wasting may be seen. 
6. Skin over the knee: It may be stretched and shiny in an inflammatory 
disease. 
 
PALPATION : 
1. Local Temperature  -  may be present due to any Inflammation 
2. Swelling – 2 important test 
a. Fluctuation test 
b. Patellar tap - positive in moderate amount of fluid in knee joint. 
3. Tenderness : Tenderness on the joint line or tibio femoral joint line, 
Patello femoral joint. 
4. Irregular and enlarged looking joint due to formation of peripheral 
osteophytes. 
5. Crepitation present on moving the joint 
6. Nodules  - Loose bodies may be felt. 
7. Movement : 
a. Flexion – Normal range of movement ( 0 – 140 degrees) 
b. Extension – may be restricted 
8. Measurement : 
a. Muscle girth (10cm above the patella) – Quadriceps muscle 
wasting may be present. 
b. Measurement at joint line of knee -  for prognosis of swelling 
 
Diagnosis criteria: 
• Age greater than 40 years 
• Pain and swelling in knee joint 
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• Stiffness from the thickening of capsule and synovium 
• Crackling sensation present in knee joint while moving the joint 
• Tenderness on  the joint line 
• Osteophyte formation at the joint margins 
• Restricted joint movements 
• Deformity such as Genu varum may be present 
• Asymmetrical narrowing of the joint space. 
• Subchondral sclerosis 
• Subchondral cysts. 
• Osteophytes at the joint margin  
• Loose bodies within the joint Subluxation / dislocation at the                
later stage,  
• Deformity of joint is present 
 
Laboratory Findings: 
  There is no blood test for the diagnosis of osteoarthritis.  Blood test are 
performed to exclude diseases that can cause secondary osteoarthritis. 
 
  These consist of the following 
• Serological tests and ESR to rule out Rheumatoid arthritis 
• Serum uric acid to rule out Gout. 
• Arthroscopy, if a loose body of  frayed meniscus is suspected. 
 
Radiological features: 
  The diagnosis of osteoarthritis is mainly radiological 
• asymmetrical narrowing of the joint space 
• Subchondral Sclerosis dense bone under the articular suface 
• Subchondral cysts 
• Osteophytes at the joint margin 
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• Loose bodies within the joint 
• Subluxation / dislocation at the later stage 
• Deformity of joint if present. 
 
Radiological classification of knee. (Ahlbach) AP weight bearing and lateral 
views 
Type I – Joint space narrowing 
Type II – Total lost of joint space 
Type III -  <5mm tibial erosion but posterior part of the plateace infact. 
Type IV – >5mm tibial erosion and erosion of posterior plateace 
  Type V – Subluxation. 
 
COMPLICATIONS OF OSTEOARTHRITIS 
 
  The major complication of osteoarthritis of knee 
• Joint deformities  
• Capsular herniation 
• Loose bodies 
• Subluxtion 
 
RISK FACTORS: 
1. Trauma – Fractures involving the articular surface are obvious 
precursors of secondary osteoarthritis. 
2. Occupation – Osteoarthritis of the knee in workers engaged in knee – 
bending activities 
3. Increase risk in Athletes  
4. Obesity : Causes increased joint loading and predisposes to Osteoarthritis 
of knee 
5. Family history 
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MATERIALS AND METHODS 
 
  To study on clinical evaluation of the disease “AZHL KEEL VAYU” 
with the drug SAGALA VADHA CHOORANAM (INTERNAL) and ILAGU 
VADHA KESARI THYLAM (EXTERNAL) was carried out in Postgraduate 
Sirappu Maruthuvam, Government Siddha Medical College, Palayamkottai. 20 
patients of both male and female were selected for the studies and admitted in In 
patient ward for among 20 IP patients, 10 IP patients will be given massage and 
varmam treatment along with internal medicine and remaining 10 IP patients 
will be given massage fomentation without internal medicine. 
   
  Another 20 patients are treated with trial drug in the outpatient ward. 
 
SELECTION OF PATIENTS: 
INCLUSION CRITERIA: 
• Age – 40 – 65 Years 
• Sex -  Both male and female  
• Patients having symptoms of arthritis of both knee joints, swelling, 
stiffness, crepitation, restricted movements of both knee joints. 
• Patients who are willing to undergo radiological investigation and give 
blood for laboratory investigation. 
• Patient willing to sign the informed consent stating that  he/she will 
consciously stick to the treatment during 48 days but can opt out of the 
trial of his / her own conscious discretion. 
 
EXCLUSION CRITERIA: 
• Cardiac disease 
• Diabetes mellitus 
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• Hypertension 
• Rheumatoid arthritis 
• Pregnancy and lactation 
• History of trauma 
• Tuberculosis 
• Use of narcotic drugs 
• Neurological disorder 
• Patients with any other serious illness. 
 
STUDY OF CLINICAL DIAGNOSIS: 
  A case sheet is prepared on the basis of siddha and modern method to 
diagnose the disease and individual case sheet is maintained for each patient. 
 
SIDDHA DIAGNOSTIC TOOLS: 
• Poriyal arithal 
• Pulanal arithal 
• Vinathal 
• Mukkutram 
• Ezhu udal thathugal 
• Envagai Thervu 
• Thinaigal 
• Paruva kalangal 
• Thega nilai 
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LABORATORY INVESTIGATIONS: 
 
Blood   Urine 
TC    Albumin 
DC    Sugar 
ESR    Deposit 
Hb 
 
Aso  titre 
 
Radiological investigations: 
  X- ray of the knee joints  (AP and Lat view) Improvement assessed by 
following assessments. 
 
Selection of drugs: 
  Selection of drugs was made from the elaborate studyof various siddha 
literatures and finally the drugs were selected from Athma 
Rakcharmithamennum Vaidhya Sara Sankiragam. 
  The trial drugs selected are  
 
1. Sagalavatha Chooranam as internal medicine 
2. Ilagu Vadha Kesari Thylem as external medicine. 
 
LINE OF TREATMENT 
 The treatment of Siddha system includes not only the removal of signs 
and syptoms of a disease but also in total uprootment of the diseases. 
 In Azhal keel vaayu the deranged vatham is brought to its normal state by 
purgation  
 
 “tpNurdj;jhy; thjk; jhO; ; ;; ; ;; ; ; k;; ;;” 
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1. 15ml of vellai ennai is given with warm water early morning (single dose) in 
empty stomach before starting the treatment with trial drug. 
 
2. Internal medicine 
 Sagala vadha chooranam-1.5gm three times/day given with water after 
food. 
 
3. External medicine 
Ilagu vadha kesari thylam - External application. 
  Apart from other department, sirappu maruthuvam department gives 
equal important to external therapy in siddha system of medicine along with its 
internal and external medicines. 
 
EXTERNAL THERAPIES: 
 They are kattu, pattru, vaedhu, puravalayam, Thokkanam, ottradam, 
varmam, asanam etc., 
 
ASSESSMENT OF PROGNOSIS: 
1. Clinical Assessement: 
• Pain and swelling in both knee joints 
• Stiffness in both knee joint 
• Crepitation in joint line, medial condyle 
• Tenderness in joint line, medial condyle of knee joint 
• Warmth 
• Periarticular atrophy 
• Restricted movements of  both the knee joints. 
 
2. Radiological Assessment: 
  X-ray of the both knee (AP view and lateral view) 
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RESULTS AND OBSERVATION 
 
1. GENDER DISTRIBUTION: 
 
GENDER NUMBER OF CASES PERCENTAGE 
Male 18 45 
Female 22 55 
Total 40 100 
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Inference:  
           Among the 40 patients selected for this study, 45% were males and 55% were 
females. 
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2. AGE DISTRIBUTION: 
 
AGE (YEAR) NUMBER OF CASES PERCENTAGE 
40-50 6 15 
51-60 18 45 
61-70 15 37.5 
71-80 1 2.5 
TOTAL 40 100 
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Inference:  
Most of the cases were above the age group of 50. 
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RELIGION 
RELIGION NUMBER OF CASES PERCENTAGE 
Hindu 34 85 
Muslim 1 2.5 
Christian 5 12.5 
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Inference:  
Most of the cases were Hindu. 
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3. KAALAM DISTRIBUTION: 
 
KAALAM NUMBER OF CASES PERCENTAGE 
Vatha Kaalam 
(Up to 33 years) 
- - 
Pitha Kaalam 
(33years- 66 years 
32 80 
Kabha Kaalam 
(above 66 years) 
8 20 
Total 40 100 
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Inference:  
Out of 40 cases, 80 % of the cases were found to be in Pitha kaalam, and the 
remaining 20% were found to be in kabha kaalam. 
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4. OCCUPATIONAL STATUS: 
 
OCCUPATION NUMBER OF CASES PERCENTAGE 
Agriculturist 14 35 
Manual labour 15 37.5 
Home maker 11 27.5 
Total 40 100 
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Inference: 
Out of 40 cases, in this study   the rate of incidence is higher in occupational 
group which includes home maker (27.5%) and farmer & manual labour (72.5%) 
groups. 
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5. SEASONAL VARIATIONS: 
SEASONS NUMBER OF CASES PERCENTAGE 
Kaar kaalam (Aug 16 – Oct 15) 19 47.5 
Koothir kaalam (Oct 16 – Dec 15) 11 27.5 
Munpani kaalam (Dec 16 – Feb15) 0 0 
Pinpani kaalam (Feb 16 – Apr 15) 0 0 
Elavenil kaalam (Apr 16 – June 15) 0 0 
Muthuvenil kaalam (June 16 – Aug 15) 10 25 
Total 40 100 
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Inference:   
          Out of 40 cases, 19 patients (47.5%) were admitted in Kaar Kaalam, 11 patients 
(27.5%) were admitted in koothir kalam and 10 patients (25%) were admitted in 
Muthuvenil Kaalam. 
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6. THINAI: 
 
THINAI NO OF CASES PERCENTAGE 
Kurinji (Hill Area) 1 2.5 
Mullai (Forest Area) 0 0 
Marutham (Fertile Land) 30 75 
Neithal (Coastal Area) 9 22.5 
Paalai  (Desert Land) 0 0 
Total 40 100 
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Inference:  
 Among the 40 patients, 1 patient (2.5 %) was from Kurinji, 30 (75%) cases 
were from Marutham and 9 (22.5 %) cases were from Neithal thinai. 
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7.  SOCIO- ECONOMIC STATUS: 
 
CLASS NUMBER OF CASES PERCENTAGE 
Lower 31 77.5 
Middle class 7 17.5 
Rich 2 5 
Total 40 100 
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Inference: Out of 40 cases 77.5% of cases were lower class, 17.5 % cases were from 
middle class and the remaining 5% were rich. 
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8. DIETARY HABITS 
 
Dietary Habits No of Cases Percentage 
Vegetarian 3 7.5 
Non vegetarian 37 92.5 
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Observation: 
All the cases except three were mixed diet. 
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9.  PRECIPITATING FACTORS: 
 
PRECIPITATING FACTORS NO OF CASES PERCENTAGE 
Obesity 5 12.5 
Menopause 0 0 
Occupation related  
 (over use of the joint) 
23 57.5 
H/o trauma 2 5 
Hereditary 10 25 
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  Inference: 
Among the 40 patients, 5 of them (12.5%) were overweight, 23 of them (57.5 
%) had the history of over use of the joint and 7 (17.5 %) of them were in the post 
menopausal stage. 
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DURATION OF ILLNESS 
DURATION 
(MONTHS) 
NO. OF CASES PERCENTAGE 
0-3 14 35 
3-6 11 27.5 
6-12 9 22.5 
12-24 4 10 
Above 24 2 5 
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Inference 
 Among the 40 cases most of them had the duration of illness – upto 1 year. 
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10.MODE OF ONSET: 
 
MODE OF ONSET NO. OF CASES PERCENTAGE 
Acute 5 12.5 
Gradual 35 87.5 
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Inference: 
 According to this study 87.5% of cases were reported gradual onset of disease. 
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11. CLINICAL FEATURES: 
CLINICAL FEATURES NO. OF CASES PERCENTAGE 
Pain & Tenderness 40 100 
Swelling 29 72.5 
Morning stiffness 15 37.5 
Crepitations 40 100 
Deformity 6 15 
Restricted movements 38 95 
Constipation 20 50 
Sleeplessness 15 37.5 
Muscle wasting 3 7.5 
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Inference: 
 Among the forty cases all of them had pain, tenderness, crepitations and 
restricted movements. 29 patients had swelling and 15 patients had morning stiffness. 
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MEASUREMENTS OF THE KNEE JOINTS 
Before treatment After treatment 
S.No 
Patient 
Name 
Age/ 
sex 
OP/IP 
No 
Right 
(cm) 
Left 
(cm) 
Right 
(cm) 
Left 
(cm) 
1 Mary 60/F 56197 32 32 31 31 
2 Senthil arumugam 59/F 69330 35 34.5 34 34 
3 Gowri 52/F 71707 34 33 32 32 
4 Saraswathi 60/F 65682 33 33.5 32 32 
5 Pushpam 65/F 59255 35 35 35 34.5 
6 Shanmugavel 62/M 73154 34 34.5 34 34 
7 Servarayan 55/M 68070 35 35 35 35 
8 Kallathiyan 63/M 58435 35 35 34 34.5 
9 Komathi 60/F 66916 33 33.5 33 33 
10 Shanmugavel 65/M 67915 34 34.5 34 34 
11 Selvi 67/F 2405 34 34 33 33 
12 Nachiyar 50/F 2332 33 35 33 34.5 
13 Govindan 55/M 2794 39 40 39 39 
14 Ramalakshmi 60/F 2965 35 35 35 34 
15 Sathya 68/M 3263 39 40 39 39 
16 Ponnuthai 45/F 3103 35 34 36 34 
17 Maryammal 55/F 3109 36 35 35 34 
18 Pathlamuthu 57/M 4008 36 37 36 36 
19 Nambi 70/M 3960 31 32 31 31 
20 Muthu 56/M 4185 35 36 35 35 
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14. TABLE SHOWING RADIOLOGICAL FINDINGS: 
 
FINDINGS NO. OF CASES PERCENTAGE 
Joint space narrowing 38 95 
Inter condylar notch prominence 6 15 
Presence of osteophytes 30 75 
Subchondral sclerosis 38 95 
Osteoporosis 10 25 
                  Deformity 6 15 
          Soft tissues swelling 3 7.5 
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Inference: 
 Joint Space narrowed in  38 cases (95%), Osteophytes present in 30 cases 
(75%), Subchondral sclerosis  present in 38 cases (95%), Osteoporosis present in 10 
cases (25%). 
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14. TABLE SHOWING THE DERANGEMENT OF VATHAM: 
 
VATHAM NO. OF CASES PERCENTAGE 
Pranan 1 2.5 
Abanan 35 87.5 
Viyanan 40 100 
Udhanan 0 0 
Samanan 40 100 
Naagan 0 0 
Koorman 7 17.5 
Kirukaran 0 0 
Devathathan 25 62.5 
Dhananjeyan 0 0 
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Inference: 
    Viyanan and Samanan were affected in all the 40 cases (100%), Abanan was 
affected in 35 cases (87.5%),Devathathan was affected in 24 cases (62.5%), Koorman 
was affected in 7 cases (17.5%) and pranan was affected in 1 cases (2.5%). 
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15. DISTUBRANCES IN PITHAM: 
 
PITHAM NO. OF CASES PERCENTAGE 
Analapitham 10 25 
Ranjagam 12 30 
Saathagam 40 100 
Prasagam 0 0 
Alosagam 0 0 
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Inference:  
Saathaga Pitham was affected in all 40 cases (100%), ranjaga pitham was 
affected in 12 cases (30%) and Analpitham was affected in 10 cases (25%). 
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16. TABLE SHOWING THE DERANGEMENT OF KABHAM: 
 
KABHAM NO. OF CASES PERCENTAGE 
Avalambagam 40 100 
Kilethagam 10 25 
Pothagam 0 0 
Tharpagam 0 0 
Santhigam 40 100 
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Inference: 
      In all the 40 cases (100%) Santhigam was affected and so Avalambagam was also 
affected. 10 cases kilethagam was affected.  
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17. TABLE SHOWING THE CONDITION OF UDAL KATTUGAL: 
 
UDAL KATTUGAL NO. OF CASES PERCENTAGE 
Saaram 40 100 
Senneer 12 30 
Oon 3 7.5 
Kozhuppu 40 100 
Enbu 40 100 
Moolai 40 100 
Venneer/suronitham 0 0 
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Inference: 
 In all the cases Saaram,  Kozhuppu and Enbu were affected (100%) and 
Senneer was affected in 12cases (30%).  Oon was affected in 3 cases (7.5%). 
 
 
71 
 
18. ENNVAGAI THERVUGAL: 
 
ENNVAGAI THERVUGAL NO. OF CASES PERCENTAGE 
Sparisam 40 100 
Naa 12 30 
Niram 2 5 
Mozhi 0 0 
Vizhi 0 0 
Malam 35 87.5 
Moothiram 0 0 
Naadi 40 100 
 
Naadi  
Pitha Vatham 20 cases (50%) 
Vatha Pitham 15 cases (37.5%) 
 Pitham Kabham 5 cases (12.5%) 
Neikuri 
 Snake in ring 15 (37.5%) 
 Ring in snake 20 (50%) 
 Ring in pearl 5   (12.5%) 
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Inference:     
       Sparisam was affected in all the 40 cases, Naa was affected in 12 cases (30%), 
Malam was affected in 35 cases (87.5%). Niram was affected in 2 case (5%).  
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19. SELECTION OF PATIENTS: 
 
TREATMENT  OPTIONS NO OF PATIENTS 
Trial drugs only (Int & Ext medicine) 20 
Trial drugs +External therapies 
      (Int & Ext medicine) 
10 
External theraphy only 10 
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Inference:     
This Clinical study includes 40 Patients, i.e. 20 from IP ward and 20 Patients 
from OP ward. 20 OP patients were given both Internal and External medicines, 10 IP 
cases were given Internal, External medicine along with external therapy 10 IP cases, 
were given only External therapy. 
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20. ASSESSMENT OF RESULTS: 
OUTCOME ASSESSMENT SCALE: 
Clinical efficacy of the trial drugs were assessed by the following scales  
Universal pain assessment scale    (Mccaffiry et al., 1993) 
a) 0       -         No pain 
b) 1-3    -       Mild Pain 
c) 4-6     -        Moderate Pain 
d) 7-10   -         Severe Pain 
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A). ASSESSMENT OF CURATIVE EFFECTS IN KNEE OSTEOARTHRITIS 
PATIENTS TREATED ONLY WITH TRIAL DRUGS:(INTERNAL AND 
EXTERNAL MEDICINES) 
INITIAL READINGS FINAL READINGS 
SYMPTOMS 
NO OF PATIENTS PERCENTAGE NO OF PATIENTS PERCENTAGE 
No Pain 0 0 6 30 
Mild 4 20 8 40 
Moderate 8 40 3 15 
Severe 8 40 3 15 
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Inference: 
                Among the patients who were selected for treating alone with trial drugs, 8 
of them had severe symptoms, 8 had moderate symptoms, and the remaining 4 
patients had mild symptoms. But after treatment only 3 had severe symptoms, 3 had 
moderate symptoms, 8 had mild symptoms and 6 had no clinical manifestations. 
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B). EFFECT OF TRIAL DRUG ALONE: 
Effect of therapy is assessed from the above tabulated data. 
Effect of the Therapy No. of Patients Percentage 
Good 6 30 
Moderate 8 40 
Mild 3 15 
No 3 15 
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Inference: 
         By treating alone with trial drugs, 30% of patients had good improvement, 40% 
of patients had moderate improvement, 15% had mild improvement, and 15% had no 
improvement. 
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C). ASSESSMENT OF CURATIVE EFFECTS IN OSTEOARTHRITIS 
PATIENTS TREATED WITH TRIAL DRUGS ALONG WITH EXTERNAL 
THERAPIES. 
 
INITIAL READINGS FINAL READINGS 
SYMPTOMS 
NO. OF PATIENTS PERCENTAGE NO. OF PATIENTS PERCENTAGE 
No Pain 0 0 5 50 
Mild 1 10 4 40 
Moderate 5 50 1 10 
Severe 4 40 0 0 
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Inference: 
           Among the patients who were selected for treating both with trial drugs and 
external therapies, 4 of them had severe symptoms, 5 had moderate symptoms, and the 
remaining 1 patient had mild symptoms. But after treatment 5 had no clinical 
manifestations, 4 had only mild symptoms and the remaining 1 had moderate 
symptoms. No cases reported to have severe symptoms. 
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D). EFFECT OF TRIAL DRUG ALONG WITH EXTERNAL THERAPIES: 
 
EFFECT OF THERAPY NO. OF PATIENTS PERCENTAGE 
Good 5 50 
Moderate 4 40 
Mild 1 10 
No 0 0 
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Inference: 
         By treating both with trial drugs and external therapies, 50% of patients had 
good improvement, 40% of patients had moderate improvement and 10 % only had 
mild improvement. None were reported to have nil prognosis. 
 
 
78 
 
C). ASSESSMENT OF CURATIVE EFFECTS IN OSTEOARTHRITIS 
PATIENTS TREATED EXTERNAL THERAPIES ONLY. 
 
INITIAL READINGS FINAL READINGS 
SYMPTOMS 
NO. OF PATIENTS PERCENTAGE NO. OF PATIENTS PERCENTAGE 
No Pain 0 0 4 40 
Mild 1 10 5 50 
Moderate 5 50 1 10 
Severe 4 40 0 0 
 
           Among the patients who were selected for treating external therapies only, 4 of 
them had severe symptoms, 5 had moderate symptoms, and the remaining 1 patient 
had mild symptoms. But after treatment 4 had no clinical manifestations, 5 had only 
mild symptoms and the remaining 1 had moderate symptoms. No cases reported to 
have severe symptoms. 
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EFFECT OF THERAPY NO. OF PATIENTS PERCENTAGE 
Good 4 40 
Moderate 5 50 
Mild 1 10 
No 0 0 
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         By treating external therapies only, 40% of patients had good improvement, 50% 
of patients had moderate improvement and 10 % only had mild improvement. None 
were reported to have nil prognosis. 
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E). COMPARISON BETWEEN EFFECTIVE OF TRIAL DRUG AND TRIAL 
DRUG WITH COMPLEMENTARY THERAPIES: 
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F). OVERALL RESULTS AFTER TREATMENT: 
   Based on outcome, effects after treatment was classified into 4 grades as 
MARKED EFFECT: 
 No longer any clinical manifestations. 
 Patient could work and live normally. 
 No recurrence after some months. 
MODERATE EFFECT: 
 Moderate reduction of manifestations. 
 Slight pain after movement. 
MILD EFFECT: 
 Slight reduction in the clinical manifestation.  
 With relapse. 
NO EFFECT: 
       No reduction of pain and tenderness. 
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EFFECT OF THERAPY NO. OF CASES PERCENTAGE 
Marked effect 15 37.5 
Moderate effect 17 42.5 
Mild effect 5 12.5 
No effect 3 7.5 
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Inference: 
         Out of 40 cases, marked improvement was observed in 37.5 % patients, 
moderate improvement in 42.5 % patients, mild improvement in 12.5 % patients and 
no improvement was observed in 7.5 % patients. 
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OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP & 
IP NO 
NAME AGE SEX DOA DOD 
TREATED 
DAYS 
RESULT 
1 58435 Kallathiyan 63 M 01/08/12 06/09/12 44 MARKED 
2 54678 Jansi rani 58 F 19/07/12 27/08/12 36 MARKED 
3 55530 Saravanan 49 M 23/07/12 23/08/12 38 MODERATE 
4 74470 Velu 63 M 22/09/12 15/10/12 30 MODERATE 
5 67975 Shanmugavel 65 M 03/09/12 10/10/12 44 MODERATE 
6 68415 Ameer sulthan 50 F 04/09/12 28/09/12 31 MODERATE 
7 66916 Komathi 60 F 30/08/12 25/09/12 32 MARKED 
8 68070 Saervarayan 55 M 03/09/12 20/09/12 26 MILD 
9 73154 Shanmuga vel 62 M 18/09/12 12/10/12 30 MARKED 
10 57823 Rajan 66 M 30/07/12 29/08/12 37 MODERATE 
11 78554 Sivaraman 60 M 06/10/12 12/12/12 73 MARKED 
12 58746 Muthammal 60 F 02/08/12 25/08/12 30 MODERATE 
13 65412 Mariammal 62 F 25/08/12 10/09/12 24 MILD 
14 59255 Pushpam 65 F 04/08/12 17/08/12 20 NO 
15 65682 Saraswathy 60 F 25/08/12 15/09/12 27 MILD 
16 71707 Gowri 52 F 13/09/12 05/11/12 60 MARKED 
17 56197 Meri 60 F 25/07/12 15/09/12 57 MARKED 
18 69330 
Senthil 
Arumugam 
59 F 06/09/12 17/10/12 50 MARKED 
19 82518 Annammal 54 F 16/10/12 30/10/12 21 NO 
20 88896 Kodimuthu 65 M 06/11/12 22/11/12 23 NO 
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OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP 
& 
IP 
NO 
NAME AGE SEX DOA DOD 
TREATED 
DAYS 
RESULT 
21 2405 Selvi 67 F 25/07/12 28/08/12 34 MARKED 
22 2455 Dhanam 68 F 27/07/12 22/08/12 26 MODERATE 
23 2332 Nachiyar 50 F 19/07/12 08/08/12 20 MILD 
24 2794 Govindan 55 M 23/08/12 20/09/12 28 MARKED 
25 2965 Ramalakshmi 60 F 07/09/12 28/09/12 21 MODERATE 
26 3263 Sathya 68 M 27/09/12 20/10/12 23 MARKED 
27 3103 Ponnuthai 45 F 18/09/12 15/12/12 28 MODERATE 
28 3461 Thavamani 52 F 08/10/12 30/10/12 22 MARKED 
29 3432 Thangakani 70 F 05/10/12 25/10/12 20 MODERATE 
30 3105 Veerammal 48 F 19/10/12 15/11/12 26 MARKED 
31 3109 Meriammal 55 F 19/09/12 05/11/12 48 MODERATE 
32 3660 Vembu 55 M 25/10/12 15/11/12 20 MARKED 
33 3755 Palani 80 M 02/11/12 25/11/12 23 MODERATE 
34 4008 Pathalamuthu 57 M 23/11/12 20/12/12 27 MARKED 
35 3960 Nambi  M 20/11/12 12/12/12 22 MODERATE 
36 4042 Ramuthai 19 F 26/11/12 20/12/12 24 MODERATE 
37 4004 Baburao 67 M 23/11/12 18/12/12 25 MILD 
38 3961 Packiam 67 F 20/11/12 12/12/12 22 MARKED 
39 4185 Muthu 56 M 06/12/12 30/12/12 24 MARKED 
40 3820 Kanagaraj  M 09/11/12 28/11/12 20 MODERATE 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT- OP & IP PATIENTS
DC ESR Bl.Sugar Bl.Urea Se. Cr 
TC 
N L E HB F PP 
S. 
NO 
0P/IP 
NO 
BT AT BT AT BT AT BT AT BT AT 
BT AT 
BT AT BT AT 
BT AT BT AT 
1. 54678 8500 8700 58 60 37 37 5 2 11 12 30/60 20/40 70 72 90 100 20 25 0.3 0.2 
2. 56197 8000 8200 61 60 37 35 2 2 10 10 12/27 10/20 85 87 140 130 17 18 0.3 0.7 
3. 55530 8500 8300 60 62 35 34 5 3 13 14 7/18 7/20 80 82 100 110 25 23 0.3 0.4 
4. 58435 7700 7800 66 58 32 30 2 2 10.8 11 22/45 15/30 90 97 129 125 30 25 0.5 0.4 
5. 69330 7900 8000 69 66 28 30 3 3 10 11 20/45 20/40 71 75 110 100 19 20 0.7 0.5 
6. 71707 7900 8100 70 64 40 42 3 - 12 13 40/80 30/60 88 80 130 135 17 19 0.6 0.5 
7. 67975 8700 8500 66 68 31 35 4 2 10.5 11 11/23 15/30 86 88 86 90 48 43 0.7 0.8 
8. 74470 8100 8000 65 67 30 33 3 4 11.5 12 10/20 7/15 70 75 100 92 23 25 0.6 0.7 
9. 68415 9800 9500 58 60 39 40 3 3 11 11.5 10/20 5/10 73 85 95 100 29 30 0.7 0.5 
10. 73154 9600 9700 58 62 39 35 3 2 11 12 20/40 10/20 88 90 110 105 18 20 0.3 0.4 
11. 57823 7500 7800 41 45 25 35 4 2 11.5 12 17/35 20/40 100 88 160 150 20 25 0.8 0.9 
12. 78554 9200 9500 54 50 43 40 3 3 11.9 11.5 5/10 10/20 80 90 100 120 25 30 0.5 0.6 
13. 58746 8500 8700 60 65 40 42 4 3 9 10 20/35 20/45 80 86 110 120 30 25 0.8 0.7 
14. 65412 8600 8800 57 60 33 35 3 2 10 9 10/20 20/40 75 80 130 110 17 20 0.5 0.6 
15. 59255 7800 8000 65 60 40 35 4 2 12 12 20/35 30/60 80 90 120 130 25 28 0.3 0.7 
16. 65682 9600 9200 70 60 37 35 5 3 9 10 23/44 28/45 90 100 110 100 17 20 0.6 0.5 
17. 66916 9600 9200 60 58 35 30 4 2 10 11 15/30 20/40 80 90 110 120 20 25 0.3 0.5 
18. 68070 8500 8700 58 60 32 35 2 3 11 10 17/33 25/50 85 80 100 120 28 30 0.5 0.3 
19. 82518 9000 9200 70 68 28 33 4 2 9 10 35/60 30/60 80 90 130 125 30 35 0.7 0.8 
20. 88896 8500 8700 72 65 30 35 3 2 9.5 10.5 20/40 25/48 70 80 100 110 25 23 0.5 0.6 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
 
URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP &  IP PATIENTS0. 
DC ESR Bl. Sugar Bl. Urea Se. Cr 
TC 
N L E HB F PP 
S. 
NO 
IP. NO 
BT AT BT AT BT AT BT AT BT AT 
BT AT 
BT AT BT AT 
BT AT BT AT 
21. 2405 7000 7800 59 68 39 30 2 1 10.5 11 15/34 20/40 82 80 89 100 23 28 0.6 0.4 
22. 2455 7900 7500 66 70 30 32 4 3 9 9.5 19/40 15/35 90 85 130 140 19 26 0.8 0.7 
23. 2332 8000 8200 60 67 35 40 5 3 9.5 10 15/30 20/45 80 85 100 110 24 27 0.4 0.6 
24. 2794 9800 9500 60 72 37 35 3 2 13 13.5 12/24 13/28 85 90 110 120 28 25 0.9 0.8 
25. 2965 8000 7900 61 56 37 30 2 2 10.5 11 13/30 20/45 80 85 120 125 28 30 0.8 0.7 
26. 3263 9800 9200 65 60 29 34 6 5 13.3 13 12/25 15/30 75 80 110 120 49 38 0.9 0.6 
27. 3103 6800 7400 60 70 36 30 6 3 10.5 11 22/44 20/40 70 74 101 107 17 23 0.3 0.5 
28. 3461 9600 8800 60 62 39 42 1 2 11.6 12 11/21 20/40 80 85 120 127 30 35 0.6 0.7 
29. 3432 9000 8800 58 60 35 40 3 1 10 10.5 10/20 13/33 70 75 110 100 19 23 0.5 .08 
30. 3109 8600 9000 60 65 32 38 4 2 11.3 11.8 11/25 22/40 75 80 100 90 23 25 0.4 0.6 
31. 3660 9800 9200 70 65 30 35 4 3 12 11.5 20/40 19/25 60 80 110 130 26 28 0.6 0.5 
32. 3755 7600 8000 62 65 28 33 5 2 10.8 11 17/33 22/45 78 85 100 110 28 30 0.5 0.4 
33. 3105 8000 8500 60 65 38 40 3 1 9.8 10 22/40 17/30 68 70 100 105 24 26 0.6 0.7 
34. 4008 7700 7900 66 64 30 35 4 1 11.5 12 3/7 10/20 80 90 130 135 29 32 0.6 0.7 
35. 3960 9500 8800 69 72 20 28 1 2 9.6 10.2 28/60 20/40 80 85 110 120 42 38 0.6 0.7 
36. 4042 8300 8800 67 70 30 25 3 2 10 10.5 40/80 45/80 70 75 120 128 37 40 0.9 0.6 
37. 4004 8700 9000 70 72 28 32 4 2 10.3 10.8 45/88 40/80 80 85 110 115 40 42 0.4 0.6 
38. 3961 8800 9000 64 58 30 34 3 1 9.8 10.2 10/20 7/15 60 70 85 90 19 22 0.3 0.5 
39. 4185 6700 7200 65 70 29 32 6 3 12 11.8 4/9 10/20 70 75 85 90 28 30 0.8 0.9 
40. 3820 6200 7000 70 62 35 28 5 3 12.5 12.8 9/18 20/40 88 85 98 107 25 23 0.6 0.7 
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URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Deposits Deposits 
S. 
NO 
IP 
NO 
Albumin Sugar Pus 
Cells 
Epi. 
cells 
Albumin Sugar Pus 
cells 
Epi. 
cells 
Ova Cyst 
Occult 
blood 
Ova Cyst 
Occult 
blood 
1. 2405 NIL NIL 2-4 3-5 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
2. 2455 NIL NIL 1-2 0-2 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
3. 2332 NIL NIL 2-4 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
4. 2794 NIL NIL 3-5 2-4 NIL NIL 1-4 1-2 NIL NIL NIL NIL NIL NIL 
5. 2965 NIL NIL 1-2 2-3 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
6. 3263 NIL NIL 2-3      4-5 NIL NIL 1-2 0-3 NIL NIL NIL NIL NIL NIL 
7. 3103 NIL NIL 1-2 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
8. 3461 NIL NIL 1-2 2-4 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
9. 3432 NIL NIL 2-3 1-3 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
10. 3109 NIL NIL 1-2 1-3 NIL NIL 0-1 1-2 NIL NIL NIL NIL NIL NIL 
11. 3660 NIL NIL 1-3 1-2 NIL NIL 0-1 1-2 NIL NIL NIL NIL NIL NIL 
12. 3755 NIL NIL 1-2 0-2 NIL NIL 1-3 1-3 NIL NIL NIL NIL NIL NIL 
13. 3105 NIL NIL 1-3 0-1 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
14. 4008 NIL NIL 2-4 1-2 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
15. 3960 NIL NIL 1-2 0-1 NIL NIL 2-3 1-3 NIL NIL NIL NIL NIL NIL 
16. 4042 NIL NIL 1-2 2-3 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
17. 4004 NIL NIL 2-3 1-2 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
18. 3961 NIL NIL 1-2 2-3 NIL NIL 0-1 1-2 NIL NIL NIL NIL NIL NIL 
19. 4185 NIL NIL 1-2 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
20. 3820 NIL NIL 0-1 1-2 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Deposits Deposits 
S. 
NO 
OP 
NO 
Albumin Sugar Pus 
Cells 
Epi. 
cells 
Albumin Sugar Pus 
cells 
Epi. 
cells 
Ova Cyst 
Occult 
blood 
Ova Cyst 
Occult 
blood 
21. 65682 NIL NIL 1-2 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
22. 59255 NIL NIL 2-3 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
23. 65412 NIL NIL 2-4 1-2 NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
24. 58746 NIL NIL 2-3 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
25. 78554 NIL NIL 4-5 2-3 NIL NIL 2-3 1-2 NIL NIL NIL NIL NIL NIL 
26. 57823 NIL NIL 2-4 1-2 NIL NIL 1-2 0-2 NIL NIL NIL NIL NIL NIL 
27. 73154 NIL NIL 1-2 1-2 NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
28. 68070 NIL NIL 2-3 1-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
29. 66916 NIL NIL 2-4 4-5 NIL NIL 2-3 1-2 NIL NIL NIL NIL NIL NIL 
30. 68415 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
31. 67975 NIL NIL 3-5 2-4 NIL NIL 2-3 1-2 NIL NIL NIL NIL NIL NIL 
32. 74470 NIL NIL 1-3 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
33. 55530 NIL NIL 1-2 1-3 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
34. 54678 NIL NIL 2-4 1-3 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
35. 58435 NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
36. 56197 NIL NIL 4-5 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
37. 69330 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
38. 71707 NIL NIL 2-4 4-5 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
39. 82518 NIL NIL 2-3 2-4 NIL NIL 1-2 0-1 NIL NIL NIL NIL NIL NIL 
40. 88896 NIL NIL 2-4 2-3 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
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Bone mass density 
 
S.No Patient Name Age/Sex OP& IP  No Result 
1 Servarayan 55/M 68070 4.3 
2 Rajan 66/M 57823 2.0 
3 Mary 60/F 56197 1.8 
4 Jansy rani 58/F 54678 1.5 
5 Senthi arumugam 59/F 69330 1.8 
6 Gowri 52/F 71707 2.6 
7 Maryammal 55/F 3109 2.7 
8 Ponnuthai 45/F 3103 1.3 
9 Ramalakshmi 60/F 2965 2.6 
10 Thangakani 70/F 3432 2.5 
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DISCUSSION 
            Osteoarthritis is a chronic degenerative disorder of multifactorial 
etiology characterized by loss of articular cartilage, hypertrophy of bone at 
the margins, etc., with the biochemical and morphological alterations of the 
synovial membrane and the joint capsule.  Knee pain is most frequent and 
symptomatic medical problems above 40 years people.  More than 45years 
people report joint symptoms. 
 The signs and symptoms of  Azhal keel vayu described in Siddha 
literature can be correlated with “Osteoarthritis of knee” in modern medicine 
40 cases were selected and the diagnosis was made with the help of siddha 
method along with modern methods.  The various criteria and the results 
were discussed here under. 
Age distribution: 
According to this study, most of the patients were above the age of 50 
which was already explained by modern science that degeneration due to 
ageing is important cause for osteoarthritis. 
Sex Distribution: 
Among the 40 cases, 18 (45%) were male and 22 (55%) were female 
patients.   
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Prevalence of affecting the joints: 
In Azhal Keel Vayu the hallmark of involvements are articular joints, 
perdominantly Knee Joint (100%). 
Duration of the illness: 
According to this study the duration of the illness varied from  10 
days  to  5 years. 
Socio – economic status: 
Among the 40 cases selected for this study, 31 cases (77.5%) were 
poor class, 7 cases (17.5%) middle class and  only 2 cases (5%) were from 
rich background. 
Occupation status: 
Occupation place the important role in the aetiology of Azhal Keel 
Vayu. Manual labour account for 37.5% cases.  Agricultural labour 35% and 
home workers 27.5% were also affected by the diseases.  The main cause for 
this is excessive repetitive joint loading. 
Precipitating Factors: 
Ageing is the common cause for Azhal Keel Vayu.  Apart from that 
over use of joints due to their occupation in (57.5%)  over weight in (12.5%) 
of cases. 
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Clinical Manifestation: 
The major clinical symptom reported to be pain in the joints and 
tenderness along joint line and crepitation (100%) in the knee joints 
followed by  50% of them had constipation 37.5% of them had morning 
stiffness 95% had limited duration of movements and  72.5% had swelling in 
knee joint. 
Paruva Kaalam: 
Kaar Kalam (47.5%), Koothir Kalam as (27.5%), Muthuvenil kalam 
(25%) 
Thinnai: 
The incidence of Azhal Keelvayu is high in people from Marutha 
Nilam (75%) Neithal Nilam (22.5%) and kurinji Nilam (2.5%). 
Generally in marutha nilam, all the three doshas are in physiological 
ratio, but for these 40 patients the occupation, age and Pollution alters the 
physiological ratio and cause the disease. 
Diet: 
Diet plays a major role in maintaining ideal body mass index.  
Majority of the people (92.56%) were non-vegetarian diet habits.  
 92 
Clinical features 
 From the tabulated data, it was clear that all the patients had pain, 
tenderness, crepitations as their predominating symptoms.  Limited 
movements (95%), swelling (72.5%) and morning stiffness (37.5) were 
found to be predominent next to the above symptoms. 
Radiological findings 
 From the table data, joint space narrowing (95%), presence of 
osteophytes (75%), Subchondral sclerosis (95%) are their predominating 
findings. 
Disturbance in Vatham: 
In the 40 cases,  in all of them (100%) Viyanan and Samanan were 
affected.  Abanan was affected in 35 (87.5%) cases 
Disturbance in Pitham: 
According to this study, Sathagapitham was affected in all 40 cases 
100%.  
Disturbance in Kapham: 
According to this study santhiga kapham was affected in all the cases 
(100%).  Therefore Avalambagam also affected in 40 cases (100%). 
Kilethagam was affected in 10(25%) cases. 
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Udal Kattugal: 
Among the Seven Udal Kattugal, Saaram, Kozhuppu, Enbu and 
Moolai were affected in all 40 (100%) cases. Senneer was affected in 12 
(30%). Oon was affected in 3 cases (7.5%). 
Derangement in eight parameters of our systems (Envagi thervugal): 
 Sparisam (swelling, warmth and crepitation) was found affected in all 
the 40 cases. 
 In naadi pitha vatha naadi (50%) and vatha pitha naadi (37.5%) 
predominates among the other naadi in the osteoarthritis patients. 
Treatment: 
 The treatment of Siddha system primarily aimed to retain the 
deranged thosams and then providing relief from symptoms. 
 Each patient was advised for purgation by giving vellai ennai – 15ml 
with warm water early morning (single dose for first day treatment) 
 From 2
nd
 day onwards Internal medicine – sagala vatha choornam – 
1.5gm three times/ day. 
 External medicine – Ilagu vadha Kesari thylam were given . 
 During treatment, the patient were advised particularly to avoid foods 
which increases vatham like potato, tuber and other roots  and also advised 
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to take vitamin C containing foods and fruits.  It is important in the 
development of normal cartilage. 
 Out of 40 cases 10 cases were given only external therapy like 
ottradam, thokkanam, varmam, leaf  kattu and asana. 
 The result is mainly assessed by reduction in severity of joint pain, 
stiffness and improvement of restricted movements.  Universal pain 
assessment scale was used to infer proper outcomes. 
 The swelling of knee joint marked reducing in lemon ottradam and 
pain was reduced by Adathoda leaf  kattu. 
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SUMMARY 
 The disease Azhal Keel vaayu was comparatively studied with the 
disease Osteoarthritis with reference to its etiology, pathogenesis and 
clinical features.  Sagalavatha Chooranam as internal medicine and Ilagu 
Vatha Kaesari Thylam as external medicine was selected and a clinical 
trial in Govt. Siddha Medical College, Palayamkottai was conducted with 
these drugs. For this 40 cases were selected in which 20 were treated in 
OutPatient ward and remaining 20 in In Patient ward.  
Pharmacological analysis of Sagalavatha Chooranam shows 
 Analgesic action 
 Moderate Acute anti inflammatory action 
Pharmacological analysis of Ilagu vadha kesari thylam shows 
 Significant acute anti inflammatory action 
Since external therapies or manual therapies like massage, 
fomentation, leaf bandage, exercises plays a significant role in treating 
Osteoarthritis. Some of the external therapies from siddha system are 
manipulated along with trial drugs depending upon the severity of the 
disease. 
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Daily progress was observed to evaluate the efficacy. The results 
obtained were found to be auspicious. Particularly results by external 
therapies were found to be very auspicious. 
 During and after the course of treatment no side effects were reported. 
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CONCLUSION 
  In this clinical study SAGALA VADHA CHOORANAM  ILAGAU 
VADHA KESARI THYLAM were taken as Internal and External drug 
respectively for treating the disease Azhal Keel Vayu. 
In the pre clinical study pharmacological evaluation of the trial drug shows 
  → Significant analgesic effect 
 → Moderate Acute Anti Inflammatory effect (Internal medicine) 
 → Significant Acute Anti- Inflammatory effect (External medicine) 
The overall results of efficacy of the trial drugs along with external 
therapies by reducing the clinical signs and symptoms like pain, swelling, 
morning  stiffness. This Clinical study were found to have marked effect in 
37.5% cases, moderate effect in 42.5% cases, mild effect in 12.5% cases and 
no effect in 7.5%. 
So the clinical effect of the trial drugs along with external therapies 
was found to be moderater in treating the disease azhal keel vayu. 
 The Trial drug Sagala Vadha Chooranam and Ilagu Vadha Kesari 
Thylam is purely herbal.  No adverse effects were noticed during the 
treatment period. So the trial medicine is safe and easily preparable 
medicine. 
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ANNEXURE  - I 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF 
SAGALA VADHA CHOORANAM  (Internal)   AND ILAGU VADHA 
KESARI THYLAM (External) 
SOURCE OF RAW DRUGS: 
           The required drugs for preparation of SAGALA VADHA CHOORANAM 
(Internal)  and  ILAGU VADHA KESARI THYLAM (External)  are purchased 
from a well reputed country shop and Raw drugs are Authenticated by Medical 
botanist of Govt. Siddha Medical College, Palayamkottai, then  purified and the  
medicines are prepared in the  Gunapadam laboratory of Govt. Siddha Medical 
College, Palayamkottai. 
PREPARATION  AND PROPERTIES OF TRIAL DRUG 
 
Name of the medicine:  SAGALA VADHA CHOORANAM 
 
Reference :  Athma Rakhsharmithamennum Vaidhya Sara Sankiragam 
 
INGREDIENTS OF TRIAL DRUG: 
  Cithira moola verpattai (Plumbago zeylanica)  - 175 gms  
 Melakaranai verpattai (Toddalia asiatica)   - 175 gms 
 Nochi Verpattai (Vitex negundo)    - 175gms 
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PURIFICATION: 
Chithira moola verpattai: 
  The root bark of plumbago zeylanica is powdered and its steamed 
with milk. 
  Other milakaranai and nochi verpattai are cleaned with water and 
allowed to dry. 
 
Method of preparations: 
  The all ingredients are powdered, mixed together and taken. 
Dose :  1.5gms (Thirikadi piramanam) given with water 
Indication : All types of vatha disease 
 
 
2. Name of the medicine  :   ILAGU VADHA KESARI THYLAM 
 
 Reference :  Anubava vaidhya deva ragasiyam 
 
INGREDIENTS OF TRIAL DRUG: 
 
Sesamum oil (Juice of cleome viscosa) - 350ml 
Poondu (Allium Sativa)    - 100gms 
Perungayam (Ferula asafoetida)   - 17gms 
Moosambaram (Aloe barbedensis)  - 17gms 
 
METHOD OF PREPARTION: 
  Perungayam and moosambaram are powdered. Then vellai poondu is 
added and mixed into a paste. The paste is then taken in a vessel along with 
herbal juices and oil and heated until contents become wax like consistency.  
It is filtered and used for external application. 
 
Dose :  30 ml 
Indication :  Kai, kaal kudaichal, Vali, Veekam, Keel Vayu, Mega Soolai. 
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PROPERTIES OF TRIAL DRUG : (INTERNAL) 
nfhbNtyp: 
  Botanical name : Plumbago zeylanica 
 Family  : Plumbaginaceae  
 Parts used  : Root bark 
 NtWngah;fs; : mzpQ;rpy;> mjpfehhp> moy;> cjhzd;>  
vhp> vOeh> xyp> fUehfk;> fdyp>  
fhhpik> nfhLNtyp> ehdpype;jpud;>  
fhdpyk;> rpj;jpu%yp> joy;> cd;dp>  
mf;dp> nfhb td;dp 
  Rit   : fhh;g;G> tpWtpWg;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
 tshpay;G  : ,e;jpahtpy; vq;Fk; fpilf;ff;$baJ.   
ngUk;ghYk; ,J NtypfspYk; 
Gjh;fspYk; gapuhFk; 
 nra;if  : Kiwntg;gfw;wp  (Anti-perdiodic) 
     tpah;itAz;lhf;fp (Diaphoretic) 
 
 Rj;jpKiw  : Nth;gl;ilia ghypy; Ntf itj;J  
vLj;Jf; nfhs;s Rj;jp 
 
nghJFzk;:;;;  
  fl;btpu zq;fpue;jp fhy;fs; miuahg;Gf;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 fl;bf;R+ iytPf;fq; fho;%yk;  Kl;buj;jf;; ; P ; ; ; ; ; ; ;; ; P ; ; ; ; ; ; ;; ; P ; ; ; ; ; ; ; 
 fl;LeP Nuw;wq; fdj;j ngUtapWk;; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; 
 ml;Lq; nfhbNtyp ahk;.; ; ;; ; ;; ; ;  
 
Constituents: 
 It contain anti -oxidative property 
  Zeylaedon, chitradon, plumbagin, amino acid 
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2. kpsfuiz: 
  Botanical Name : Toddalia asiatica 
 Family  : Rutaceae 
 Parts used  : Root bark 
 Rit   : Jth;g;G 
 jd;ik  : jl;gk; 
 gphpT   : fhh;g;G 
 tshpay;G  : ,J xUtiff; nfhb 
 nra;if  : cukhf;fp (Tonic) 
     tpah;it ngUf;fp  (Diaphoretic) 
     Kiwntg;gfw;wp  (Antiperiodic) 
nghJFzk;:;;;  
  Iak fw;Wk; mrPuzth jk;Nghf;FQ;; ; P ; ; ;; ; P ; ; ;; ; P ; ; ; 
 nra;agpj;j R+iyfisj; jPh;f;Fq;fhz ; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ; - igatUk;;;; 
 <is ,Uky; ,iug;Gg;G re;njhiyf;Fk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 ehS kpsfuiz ed;W;;;  
 
nghUs; :;;;  
  ,J Iak;> Iag;ngUf;F> mrPuzk;> thjk;> moy; R+iy> ,Uky;> 
,isg;G> tapw;Wg;ghuk;>  Mfpa ,itfis ePf;Fk;. 
 
Constituents: 
  Chelerythin, Oxyclerthin, Toddanin, Coumarin, Cyclohexylamine 
 Root bark contain a resin, essential oil, citri acid, pectin, starch, chief 
constituent is berberine. 
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3. nehr;rp;;;  
  Botanical Name  : Vitex negundo 
 Family   : Verbenaceae 
 Parts used   : Rootbark 
 NtW ngah;fs;  : ,e;jpu R+hpak;> epj;jpy;> ePh;f;Fd;b>   
neh;f;Fz;b> rpe;Jk rpe;Jthuk; 
 Rit    : ifg;G>  Jth;g;G> fhh;g;G 
 jd;ik   : ntg;gk; 
 gphpT    : fhh;g;G 
 tshpay;G   : ,e;jpah KOtJk; tsUfpd;w xU  
rpwa kuk;. 
 nra;if   : ntg;gfw;wp  (Febrifuge) 
      rpWePh;ngUf;fp  (Diuretic) 
 
nghJFzk;:;;;  
  .... fu nehr;rpw; gl;ilaJ; ; ;; ; ;; ; ;  
 Js;Srd;dp thj kfw;Wk;; ; ; ;; ; ; ;; ; ; ; 
 
nghUs;:;;;  
  ,jdhy; Kg;gpzpAk;. thjNehAk; FzkhFk;. 
 
rpwg;G:;;;  
  Nehah fypia nehbf;F dUe;j ntk;ik; ; ;; ; ;; ; ;  
 NahNah kzh;S Kah;j;Jitf;  ; ; ; ;; ; ; ;; ; ; ; - fha  
 te;jKjy; ez;ghfp thjj;ij ; ; ; ;; ; ; ;; ; ; ; - NaAnthw;;;; 
  rpe;Jth uq;fdYe; jP; ; ; P; ; ; P; ; ; P 
 
nghUs; :;;;  
  clypd; ntk;ikia Nghf;fp ehSf;F ehs; cld; td;ikiag; 
ngUf;fp> tspf;Fw;wj;ijj; jd;dpiyapy; epw;fr; nra;Ak;. 
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Constituents: 
Major -  Negundoside, Nishindaside 
Other -  Viridiflorol, p – eudesmol, methyl heptanone, carophyllene, 
linatool, camphor geranoil 
Pharmacology – vitex negudo extract showed anti-inflammatory activity and 
is used in arthritis and Rheumatic disorder. 
  It also showed analgesic and central nervous system depressant 
activity 
  Major therapeutic claims :   Anti inflammatory , Antifertility, 
Antispasmodic, Anti bacterial, Analgesic, Hepato protective, Anti 
convulsant. 
 Very efficacious in dispelling inflammatory swelling of the joints. 
     Indian Medicinal plants Vol – 3 
 
Properties of Trial drug :  (External) 
1. ey;Ntis;;;  
 Botanical name : Cleome viscosa 
 Family  : Capparidaceae 
 Parts used  : Whole plant 
 Rit   : fhh;g;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
 tshpay;G  : vq;Fk; fpilf;Fk; rpW G+z;L. 
 nra;if  : GOf;nfhy;yp  (Anthelmintic) 
     ,rptfw;wp  (Antispasmodic) 
     tpah;itngUf;fp  (Diaphoretic) 
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nghJFzk;:;;;  
  ey;yNt isg;G+z;il ehLq;fhy; thjKk;Nghk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 nrhy;Yik;;;  aj;JlNd NrhigaWk;>  nky;ynky;y; ; ; ;; ; ; ;; ; ; ;  
 jf;f td nrk;gpj;Je; jhndOk; ; ; ;; ; ; ;; ; ; ; ;GQ; rhe;jkpd;wp; ; ; ;; ; ; ;; ; ; ;  
 mf;fuNeha; kpQ;R kwp; ; ;; ; ;; ; ;  
 
Constituents :  Cleomiscosin D, Coumarino  - Lingam, Glucosinolates, 
Cleomeolide 
Action :  Anti-Inflammatory, Anti-oxidative 
 
2. G+z;L:;;;  
 
Botanical Name  : Allium sativum 
Family   : Liliaceae 
Parts used   : Tuber 
NtWngah;   : ,yRdk;> fhak;> nts;isG+z;L 
Rit    : fhh;g;G 
jd;ik   : ntg;gk; 
gphpT    : fhh;g;G 
tshpay;G   : vy;yh ghfq;fspYk; gapuhFk; xUtif  
G+z;L 
nra;if   : mfl;Ltha;tfw;wp  (Carminative) 
     cukhf;fp  (Tonic) 
nghJFzk;:;;;  
 
 rd;dpnahL thje; jiyNehT jhd;typ; ; ;; ; ;; ; ;  
 kd;dptU ePh;f;Nfhit td;rPjk; ; P ; ; ; P ;; P ; ; ; P ;; P ; ; ; P ; -  md;dNk;;;  
 cs;Ss;sp fz;gha; cis%y NuhfKk; Nghk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 nts;Ss;sp jd;dhy; ntUz;L; ; ; ; ;; ; ; ; ;; ; ; ; ;  
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Constituents :   
  Allicin, spirostanol, Analogue, Quarcitin, mysicetin,  luliolin.  
  It act as a good antispasmodic.  Externally the juice used as a 
rubefacient acts very beneficial spasmodic affections & arthritis.  
3. ngUq;fhak;:; ;; ;; ;  
  Botanical Name : Ferula asafoetida 
 Family  : Umbelliferae 
 Parts used  : Oleogum resin 
  NtWngah;  : ,uzk;> fe;jp> re;Jehrk;. 
  Rit   : ifg;G> fufug;G 
 jd;ik   : ntg;gk; 
 gphpT   : fhh;g;G 
 
nra;if   :   ntg;gKz;lhf;fp  (Stimulant) 
     ,rptfw;wp  (Antispasmodic) 
nghJFzk;:;;;  
  je;jNt je;j %yj;njOk;gpzp; ; ; ;; ; ; ;; ; ; ;  
  rUtfhsk; tpUr;rpfq;fPlk;kh; ; ; P ;; ; ; P ;; ; ; P ;  
 ke;jk;thjk;  cjhth;j;jk; my;fy;Neha;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; 
  khh;gzq;fl;l Fd;kk;kNfhjuk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 ce;Jnfh;g;gj;jpd; tpj;jpuQ;R+iyr; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; ;R+h;; ;; ;; ; 
  cjpug;G+r;rp rpNyj;Jkj;JWk; typ; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 te;jnka;f;fLg; NghbitKw;WNk; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  khAehWew; fhaq;fpilf;fpNd; ; ;; ; ;; ; ;  
 
Constiuents :  
  Presence of sulphur compounds like disulfides, Glucosonic acid, 
galactose, Grahenoise, umbelliferone, Coumarine, Foelidin. 
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4. %rhk;guk;:; ;; ;; ;  
  Botanical Name : Aloe littoralis 
 Family  : Liliaceae 
 Parts used  : Latex 
 Rit   : ifg;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
  nra;if  :  cukhf;fp (Tonic) 
     ntg;gKz;lhf;fp  (Stimulant) 
 
nghJFzk;:;;;  
  khh;Gtyp tPf;fk; tapw;Wtyp gf;fNeha;; P ; ; ; ; ;; P ; ; ; ; ;; P ; ; ; ; ; 
 thh;Nkff; fl;bna; ; ;; ; ;; ; ; hL khthjk; ;;; -  ghUyfpy;;;; 
 ePsq;if fhsy; epiyR+iy Aq; fWjjP ; ; ;P ; ; ;P ; ; ;  
 Nghse; jidf;fhzpw; Nghk;.; ; ; ;; ; ; ;; ; ; ;  
 
Constituents: 
 Used in areas around joint information and swelling. 
 It  inhibits production of Inflammatory prostaglandins. 
 
 
5. ey;nyz;nza;:; ; ;; ; ;; ; ;  
  Botanical Name  :   Sesamum indicum 
 Family   :  Pedaliaceae  
 Parts used   :  Seed 
 
 nra;if   :   cs;soyhw;wp  (Demulcent) 
     clYukhf;fp  (Nutritive) 
     twl;rpafw;wp  (Emulcient) 
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nghJFzk;:;;;  
  Gj;jpeadf;Fsph;r;rp G+hpg;G nka;g;GsfQ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 rj;Jtq; fe;jp jdpapsik ; ; ;; ; ;; ; ; - nkj;jTz;lhq;; ; ;; ; ;; ; ; 
 fz;Nzha;; ;; ;; ; nrtpNeha; fghytoy; fhrNeha;; ; ;; ; ;; ; ; 
 Gz;Nzha; Nghnkz;nza;ahw; Nghw;W.; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 
Chemical Constituents: 
  Seeds contain Fixed oil, Protein, Carbohydrate 
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ANNEXURE - II 
GOVT SIDDHA MEDICAL COLLEGE- PALAYAMKOTTAI 
BIO – CHEMICAL ANALYSIS OF SAGALA VATHA CHOORANAM 
 
PREPARATION OF THE EXTRACT: 
5gms of the drug was weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water added to it and dissolved well.  Then it was 
boiled well for about 10 minutes. It was cooled and filtered in a 100ml volumetric 
flask and then it is made up to 100ml with distilled water.  This fluid was taken for 
analysis. 
 
Qualitative Analysis 
 
S.No. Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract is 
taken in a clean test tube.  To this add 
2 ml of 4% ammonium oxalate 
solution. 
No  white 
precipitate is 
formed. 
Absence of 
calcium. 
2. Test for sulphate: 
2ml of the extract is added to 5% 
barium chloride solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of   
sulphate. 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of 
chloride. 
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4. Test for carbonate 
The substance is treated with 
concentrated HCl. 
No brisk 
effervescence 
is formed. 
Absence of 
carbonate. 
5. Test for Starch 
The extract is added with potassium 
ferro cyanide. 
Blue colour is 
formed 
Indicates the 
presence of  
Starch 
6. Test for iron Ferric 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide. 
No blue 
colour is 
formed. 
Absence of 
ferric iron. 
7. Test for iron Ferrous: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cyanate. 
Blood red 
colour is 
formed. 
Indicates the 
presence of 
ferrous iron. 
8. Test for phosphate 
The extract is treated with ammonium 
molybdate and concentrated nitric 
acid. 
Yellow 
precipitate is 
formed. 
Indicates trace 
amount of  
phosphate is 
present 
9. Test for albumin 
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin. 
10. Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No Blue black 
precipitate  is 
formed 
 
 
Absence of   
Tannic acid 
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11. Test for unsaturation 
Potassium permanganate solution is 
added to the extract. 
It gets 
decolorized. 
Indicates the 
presence of 
unsaturated 
compound. 
12. Test for the reducing sugar 
5ml of benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 mts and added 8-10 drops of 
the extract and again boil it for 2 mts. 
No Colour 
change occurs. 
Absence of 
reducing sugar 
13. Test for amino acid: 
One or two drops of the extract are 
placed on a filter paper and dried it 
well. After drying, 1% ninhydrin is 
sprayed over the same and dried it 
well. 
Violet colour 
is formed. 
Indicates the 
presence of 
Amino acid. 
 
 
14. Test for zinc: 
The extract is treated with potassium 
ferrocyanide 
No white 
precipitated is 
formed 
Absence of zinc 
 
Result: 
The trial drug SAGALA VATHA CHOORANAM contains 
1. Sulphate 
2. Chloride 
3. Starch 
4. Ferrous iron 
5. Phosphate 
6. Unsaturated compound 
7. Amino acid 
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ANNEXURE – III 
GOVT SIDDHA MEDICAL COLLEGE- PALAYAMKOTTAI 
PHARMACOLOGICAL ANALYSIS  
ANALGESIC STUDY OF SAGALA VATHA CHOORANAM 
 
Aim: 
 To study the analgesic effect on albino rats by tail flick method. 
Preparation of the test Drug: 
            1 gram of  Sagala vatha chooranam was suspended in 10ml of  Hot 
Water as suspending agent. This 1 ml contained 100mg of the test drug. 
 
Procedure: 
                 Nine Male Healthy albino rats (weighing 80-100gms) were used for this 
study. The animals were allowed, free access to food and water until they brought 
for the experiment. The animals which showed the positive response to the 
stimulus (within a given time) were selected for the study. After the selection of 
animals which were responding to stimulus within 2 seconds, they were divided 
into three groups, each group consisting of three rats. 
                 The hot water was maintained at 55°C. The tip of the tail was immersed 
into the water bath and the time was noted when the rat flicked the tail. First group 
was given 1ml of water and kept as control. Second group was administered with 
paracetamol at a dose of 20mg/100gm of body weight. Third group as given the 
dose of 100mg/100gm body weight of the animal .After the drug administration, 
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the reaction time of each rat after half an hour and one hour were noted in each 
group (when a rat fails to flick the tail, it should not be continued beyond 8 
seconds to avoid injury) and the average was calculated. 
  The results of control group, standard group and drug treated group were 
tabulated and compared. 
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STUDY OF ANALGESIC EFFECT USING THE DRUG SAGALA VATHA 
CHOORANAM 
 
After drug administration  
Name of the 
Groups 
 
Dose/ 
100 
gram 
body 
weight 
 
 
Initial 
reading 
 
½ hr 
Average 
 
1 hr 
Average 
 
 
Mean 
difference 
 
Control 
(Water) 
 
 
2 ml 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
Standard 
(Paracetamol) 
 
 
2 mg 
 
2.5 sec 
 
4.5 sec 
 
6.5 sec 
 
6.5 sec 
 
Test drug 
(Sagala vatha 
chooranam) 
 
100 mg 
 
2.5 sec 
 
4.0 sec 
 
5.5 sec 
 
5.5sec 
 
Inference: 
                The trial drug had significant analgesic action. 
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STUDY OF ACUTE ANTI – INFLAMMATORY ACTIVITY IN RATS 
USING THE DRUG  
SAGALA VATHA CHOORANAM 
BY HIND – PAW METHOD 
Aim: 
 To demonstrate the acute anti-inflammatory activity of Sagala vatha 
chooranam in albino rats by Hind-paw method. 
 
Procedure: 
  
 Nine healthy albino rats weighing 100-150 gm were taken and divided into 
three groups, each consisting of three rats. 
 
First group was kept as control by giving distilled water orally 2ml/100gm 
body weight. The second group was given ibuprofen at a dose of 20mg /100gm 
body weight. The third group received the test drug at a dose 100mg /100g body 
weight. 
 
Before administration of test drug, the hind-paw volumes of all rats were 
measured. This was done by dipping the hind-paw upto the tibio-tarsal junction 
into a mercury plethysmograph. While dipping the hind-paw, by pulling the 
syringe piston, the level of mercury in the centre small tube was made to coincide 
with red marking and reading was noted from the plethysmograph. 
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Soon after measurement, the drugs were administered orally. One hour 
later, a sub-cutaneous injection of 0.1ml of 1% (W/V) Carrageenan in water was 
made into plantar surface of both hind-paws of each rat. Three hours after 
carrageenan injection, the hind paw volume was measured once again. The 
difference between the initial and final volume was calculated and compared. This 
method is more suitable for studying the anti-inflammatory activity in acute 
inflammation. The values are tabulated. 
 
STUDY OF SAGALA VATHA CHOORANAM IN  
ACUTE ANTI – INFLAMMATORY ACTIVITIES 
Group 
Dose 
volume 
orally 
Initial 
reading 
Final 
reading 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control 
Water 2 
ml 
0.55 1.4 0.85 100 - 
Standard 
Ibuprofen 
20mg 
0.55 0.75 0.20 23.2 76.5 
Test drug 100mg  0.5 0.85 0.35 41.1 58.9 
 
Result: 
 The drug has moderate acute anti-inflammatory action. 
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ACUTE ANTI - INFLAMMATORY STUDY ON ILAGU VATHA 
KESARI THYLAM (EXTERNAL USE) 
BY HIND-PAW METHOD IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory activity of the test drug ILAGU VATHA 
KESARI THYLAM  
Preparation of the test drug: 
The Ilagu vatha kesari thylam was prepared as per the preparation 
given in Anubava vaidhya deva ragasiyam. 
Procedure: 
Nine healthy albino rats weighing 100-150gm were taken and divided into 
three groups, each consisting of 3 rats. 
First group was kept as control by giving distilled water of 2ml/100gm of 
body weight. The second group was kept as test group. The third group was given 
the standard drug. 
Before application of the test drug the Hind-paw volume of all the rats 
were measured. This was done by dipping the Hind-paw up to the tibio-
femoral junction into a mercury plethysmograph. While dipping the Hind-paw, 
by pulling the syringe piston, the level of mercury in the centre small tube was 
made to coincide with red marking and reading was noted from the 
plethysmograph. 
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One hour later, a sub-cutaneous injection of 0.1ml of l %( w/r)  
Carrageenan water made into plantar surface of both Hind-paw of each rat. To 
the second (last) group Ilagu vatha kesari thylam was topically applied for 
three times over the inflammed surface in a thin layer for every 15mts for an 
hour. 
  To the contol group no drug was applied over the inflammed surface. To the 
standard group the standard drug Ibuprofen in a dose of 20mg/100gm body 
weight was given. 
Three hour after injection the Hind-paw volume was measured once again.   
The difference between the initial and final volume would show the amount of 
inflammation.  Taking the volume in the control group as 100% of inflammation, 
anti – inflammatory effect of the test group is calculated. 
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EFFECT OF ILAGU VATHA KESARI THYLAM 
 
Group Drugs 
Dose 
100 
gm of 
body 
weight 
Initial 
value 
Final 
value 
Difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2ml 0.55 1.4 0.85 100 - 
Standard Ibuprofen 20mg 0.55 0.75 0.20 23.5 76.5 
Test 
drug 
IVKT Ext 0.55 0.85 0.3 35.2 64.8 
 
IVKT- ILAGU VATHA KESARI THYLAM 
 
Inference:  The test drug has Significant anti-inflammatory action externally. 
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ANNEXURE – IV 
ASSESSMENT FORMS 
 
FORM I - SCREENING FORM 
FORM II - CONSENT FORM 
FORM III - CASE  PROFORMA 
FORM IV - LABORATORY INVESTIGATIONS 
FORM V - CLINICAL ASSESSMENT 
FORM VI -  PATIENT WITHDRAWAL FORM 
FORM VII - DRUG COMPLIANCE FORM 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU 
VATHA KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
 
FORM I –SCREENING FORM 
 
 1. OP/ IP No:                                                  2. BED No:                    
 3. Sl. No:            4.   NAME:  
5. AGE:                                         6. GENDER:  
 7.   OCCUPATION:                                       8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
I. INCLUSION CRITERIA: 
1. Sex:  Both Male and Female. 
2. Pain and swelling present in knee joints. 
3. Crepitations present in knee joints.   
4. Early morning stiffness. 
5.  Tenderness 
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II. EXCLUSION CRITERIA: 
1. Diabetes Mellitus 
2. Hypertension  
3. Cardiac diseases 
4. Pregnancy and Lactation 
5. Patients with any other serious illness 
6. Peptic ulcer 
7. Severe trauma 
8. Any other systemic diseases 
 
 III. WITHDRAWAL CRITERIA: 
               1. Development of any adverse reaction (ADR 
                2. Occurrence of any other systemic illness. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU 
VATHA KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
Form: II CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
 
Signature………………….          Date……                                                                                              
Name…………………… 
 
CONSENT BY PATIENT 
 
I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and safeguard 
my body functions.  
I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of ‘SAGALA VATHA CHOORANAM 
(Internal drug & ILAGU VATHA KESARI THYLAM (External drug)’ for the 
treatment of ‘Azhal keel vaayu’ (osteoarthritis). 
Signature………………….        Date……………….                                          
 
Name………………… 
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murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid>ghisaq;Nfhl;il; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;  
gl;lNkw;gbg;G rpwg;GkUj;Jtj;Jiw; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
‘rfythj #uzk;” kw;Wk; ’,yF thj Nfrhp ijyk ;” ,tw;wpd; 
gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T 
Xg;Gjy; gbtk;; ; ;; ; ;; ; ; 
 
 
Ma;thsuhy; rhd;wspf;fg;gl;lJ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 
 ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F 
GupAk; tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp:                                 ifnahg;gk;: 
,lk;:                                   ngau;: 
 
Nehahspapd; xg;Gjy;; ; ;; ; ;; ; ; 
                   
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ cly; ,af;fj;ij 
fz;fhzp;f;fTk>; mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; 
vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; 
nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. 
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 ehd; vd;Dila Rje;jpukhfj; Nju;T nra;Ak; cupikiaf; nfhz;L 
moy; fPy; thA vd;Dk; Neha;f;fhd ‘rfy thj #uzk; ” kw;Wk; ‘ ,yF 
thj Nfrhp ijyk; “ Mfpatw;wpd;  gupfupg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
Njjp:                                     ifnahg;gk;: 
,lk;:                                  ngau;: 
Njjp:                          rhl;rpf;fhuh; ifnahg;gk;: 
,lk;:                                        ngau; 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU VATHA 
KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
FORM III – CASE PROFORMA 
1. OP/ IP No:                                           2. BED No:                            3. Sl. No:  
 4.   NAME:                                              5. AGE:                                  6. GENDER:  
 7.   OCCUPATION:                                   8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                       10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
--------------------------------------------------------------------------------------------------- 
12. COMPLAINTS & DURATION:    
13. HISTORY OF PRESENT ILLNESS:  
14. PAST HISTORY:  
15. FAMILY HISTORY: 
Lecturer                         HOD 
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16. MENSTRUAL HISTORY (If applicable):  
17. HABITS:                                  Yes               No                                                                                                                                                   
1. Smoker     
2. Alcoholic 
3. Betel nut chewer 
4. Non-Veg /Vegetarian      
5. Drug addiction                                 
18. GENERAL EXAMINATION: 
1. Body weight [Kg]         :                      
2. Height [cm]                        :                      
3. Body Temperature [oF]       :   
4. Blood Pressure (mmHg) :      
5. Pulse Rate /min.  : 
6. Heart Rate /min.   : 
7. Respiratory Rate /min.  :   
                                                        Yes            No   
8. Pallor : 
9. Jaundice :   
10. Clubbing : 
11. Cyanosis : 
12. Pedal Oedema : 
 127 
13. Lymphadenopathy    :                                        
14. Jugular venous pulsation:  
19. CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION                                Present      Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
II. PALPATION: Present            Absent 
    1. Tenderness           ………………………….. 
    2. Swelling          ……………………………  
    3. Crepitations           …………………………… 
  4. Warmth                   ……………………………… 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full           Partial              No 
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2. KNEE:  PAIN  MUSCULAR SPASM ROM 
                                             Yes   No        Yes      No           Normal        Reduced 
    i. Flexion       
         ii. Extension 
3. NEUROLOGICAL EXAMINATION: 
   i. Sensation  Normal                     Abnormal                  
   ii. Tone                         Normal                  Abnormal                   
  iii. Power                      Normal                    Abnormal                  
  iv.Muscle wasting  Present                   Absent                      
4. REFLEXES:                      Normal    Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
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20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:       No            Mild                  Moderate         Severe  
       
          i. Onset         Sudden                       Gradual              
         ii. Nature:         Local                           Diffuse        Others 
B. Nature of pain   Shooting                       Burning       Others 
   
   YES                NO 
C. Pain during movements          
II. Morning stiffness 
III.Tenderness                                                                                                                                                                       
III. Swelling             
IV. Restricted joint movements                                                                                              
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21. EXAMINATION OF OTHER SYSTEMS: 
   Normal       Abnormal 
1.  CVS  
2.  RS    
3.  CNS 
4. ABDOMEN   
            5.  GENITO-URINARY                                         
 
SIDDHA ASPECTS 
1. NILAM: 
       1. Kurinji            2. Mullai          3. Marutham       4. Neithal           5. Paalai 
2 . KAALAM: 
         1. Kaar Kaalam    2. Koothir Kaalam          3. Munpani Kaalam      
         4. Pinpani Kaalam          5. Ilavenir Kaalam 6. Muduvenir Kaalam 
3. YAAKKAI: 
 1. Vatham          2. Pitham      3. Kabam     
4. Vathapitham        5. Pithavatham    6. Kabavatham       
7. Vathakabam        8. Pithakabam              9. Kabapitham    
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4. GUNAM: 
 1. Sathuvam  2. Rasatham             3. Thamasam 
5. IYMPORIGAL:    Normal   Affected   
1.  Mei                                   ..………………………………….. 
2. Vaai                                    ……………………………………... 
3.  Kan                                   ……………………………………… 
4. Mookku                             ……………………………………… 
5.  Sevi                                   …………………………………………… 
6. KANMENDHIRIUM / KANMAVIDAYAM: 
   Normal   Affected    
1. Kai                                            …………………………………………... 
2. Kaal                                          …………………………………………... 
3. Vaai                                           ………………………………………….. 
4. Eruvaai                                      …………………………………………..  
5. Karuvaai                                    ………………………………………….. 
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7. UYIR THATHUKKAL: 
I. VATHAM:     Normal    Affected 
1. Piraanan                                      ………………………………………… 
2.  Abaanan                                    ………………………………………….    
3. Viyaanan                                 ………………………………………….   
4.  Uthaanan                                    ……………………………………    
5. Samaanan                                    ……………………………………                             
6. Naagan                                      ……………………………………….    
7. Koorman                                  …………………………………………...  
8. Kirukaran                                   …………………………………………...         
9. Devathathan                               …………………………………………     
10. Dhananjeyan                            …………………………………………  
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II. PITHAM :             Normal    Affected 
1. Analam                                     ……………………………………….         
2. Ranjagam                                 ………………………………………….   
3. Saathagam                                  ………………………………………..     
4. Aalosagam                                 ……………………………………….           
5. Prasagam                                   …………………………………….. 
III. KABAM:     Normal    Affected 
1. Avalambagam                       …………………………………………… 
2. Kilethagam                             …………………………………………… 
3. Pothagam                                 …………………………………………… 
4. Tharpagam                               ……………………………….…………... 
5. Santhigam                                …………………………………………… 
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8. UDAL THATHUKKAL: Normal   Affected 
1.  Saaram                                                     ……………………………… 
2. Senneer                                                ……………………………… 
3.  Oon                                                                 ……………………………. 
4.  Kozhuppu                                                       ……………………………. 
5. Enbu                                                                ……………………………. 
6. Moolai                                                             …………………………… 
7. Sukkilam/Suronitham                                   ……………………………. 
9. ENVAGAI THERVUGAL: 
 1 . Naadi    ……………………………………………………. 
                           Normal   Affected 
2. Sparisam                                           ………………………….. 
3. Naa                                                       …………………………… 
4. Niram                                            …………………………….. 
5. Mozhi                                                      …………………………….. 
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6. Vizhi                                                        …………………………….. 
7. Malam 
      a. Niram                                  …………………………….. 
      b. Nurai                                   …………………………….. 
      c. Kirumi                    .…………………………….. 
      d. Thanmai:    i. Irugal                 ii. Ilagal                           
  8. Moothiram: 
I. NEERKKURI   Normal    Affected 
     a. Niram                             …………………………….. 
     b . Manam                      …              …………………………….. 
     c. Edai                       …………………………….. 
     d. Nurai                    …………………………….. 
     e. Enjal                                             …………………………….. 
II. NEIKKURI: ………………………………………. 
          Vatha Neer             Pitha Neer            Kaba Neer 
 136 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU 
VATHA KESARI THYLAM  FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
Form IV - LABORATORY INVESTIGATIONS 
1. OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                      5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ENROLMENT:                        10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
Date: 
I. BLOOD: 
1. TC :    (Cells/Cumm)          
2. DC (%):   N                L                        M             E                      
3. ESR (mm) :    ½ hr                           1 hr 
4. Hb:  
Lecturer                         HOD 
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5. Total RBC:                
6. Blood Sugar:   a) Fasting                       b) Post prandial                        
7. Kidney function tests: 
              Blood urea:   Serum creatinine: 
8. Lipid profile: 
              HDL:    LDL:              VLDL:   
              Total Cholesterol :  TGL: 
9. Liver Function tests: 
              SGOT:   SGPT:  Alk. Phosphatase: 
               Albumin:  Globulin:  Total Protein: 
               Serum Bilirubin:         Total   Direct  Indirect : 
      II. URINE: 
1. Albumin :                                                    
2. Sugar :                                                           
3. Epithelial cells   :                 
4. Pus cells             :                 
5. Red blood cells  :                 
6. Casts/Crystals    : 
III. MOTION:    
1. Ova    : 
2. Cyst    : 
3. Occult blood   : 
4. Pus cells   : 
IV. X-RAY: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU 
VATHA KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
 
FORM V – CLINICAL ASSESSMENT 
1.  OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                      5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION:                    Present      Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
Lecturer                         HOD 
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II. PALPATION: Present            Absent 
    1. Tenderness            ……………………… 
    2. Swelling              …………………………  
    3. Crepitations     ……………………………… 
  4. Warmth               ……………………………… 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full         Partial              No 
2. KNEE:  PAIN MUSCULAR SPASM ROM 
                                                 Yes   No        Yes   No               Normal    Reduced 
            i. Flexion  
            ii. Extension 
3. NEUROLOGICAL EXAMINATION: 
             i. Sensation: Normal                             Abnormal                  …………... 
             ii. Tone         Normal                        Abnormal                  ………….. 
             iii. Power      Normal                              Abnormal                 ..………… 
             iv. Muscle wasting:  Present              Absent            …………. 
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4. REFLEXES:               Normal   Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:      No                  Mild       Moderate          Severe  
         i. Onset              Sudden                          Gradual              
         ii. Nature:           Local                             Diffuse          Others 
B. Nature of pain       Shooting                         Burning          Others     
       Yes                  No 
C. Pain during movements     
II. Morning stiffness 
III.Tenderness                                                                                                                                                                     
III. Swelling             
IV. Restricted joint movements                                                                                           
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU VATHA 
KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
FORM - VI PATIENT WITHDRAWAL FORM 
1.  OP / IP No       …………    2. S.No. ………………     3.Date: …………… 
4.  Name    ………………….. 5. Age ……………           6. Gender ………… 
7.  Postal address: 
-------------------------------------------------------------------------------------------------- 
Complaints and Duration: 
 
Irregular treatment: 
 
Other causes: 
 
 142 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF SAGALA VATHA CHOORANAM & ILAGU 
VATHA KESARI THYLAM FOR AZHAL KEEL VAAYU (OSTEOARTHRITIS) 
 
FORM VII - DRUG COMPLIANCE FORM 
 
Name of the Drug: SAGALA VATHA CHOORANAM  
Drugs issued: ……………(mgs/Grams) 
Drugs returned:  ……………(mgs/Grams) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                     Signature of the HOD 
DRUG TAKEN TIME 
S.NO DATE MORNING/TIM
E 
AFTERNOON/TI
ME 
NIGHT/TIM
E 
Day 1     
Day 2     
Day 3     
Day 4     
..     
..     
Up to day 
48 
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ey;nyz;nza;; ; ;; ; ;; ; ; 
dt<<<< lVf<K<<< !
 
 
 
outq!lVf<K<<<  
 
rfythj R+uzk;;;; 
,yFthj Nfrhp ijyk;;;; 
yx<xml<!< << << < (Foementation) 
wZlqs<<<<sl<!hpl<< << << <!yx<xml<< << << <!
!
!
 
,iyf;;;; fpop xw;wlk;; ;; ;; ; 
gm<M<<< !(COMPRESS) 
 
 
PATIENTS WITH SWELLING 
I.P. No:  3109 
Name :  Mariammal  Age : 55 Female 
 
I.P. No:  3103 
Name :  Ponnuthai Age : 45 Female 
 
O.P. No:  71707 
Name :  Gowri Age : 52 Female 
 
O.P. No:  69330 
Name :  Senthil Arumugam Age : 59 Female 
 
  
OSTEOARTHRITIS KNEE 
 
 
 ANATOMY OF THE KNEE JOINT 
 
 EXERCISE FOR KNEE JOINT 
 
